• World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies for the Use of Antimicrobials in Food Production Animals
• "DrugBank: A General Resource for Pharmaceutical and Pharmacological Research
• $75 million in prescription drugs stolen from warehouse
• [L’"Humanae vitae" Una profezia scientifica] (Italian)
• [Self-medication and the elderly. The reality of the home medicine cabinet] Automedicacion y ancianos. La realidad de un botiquin casero
• 17α-Ethinylestradiol hinders nucleotide excision repair in zebrafish liver cells
• 17Alpha-Ethinylestradiol induces an imbalance between apoptosis and cell proliferation to sex steroid disruption in a testis culture of gudgeon, Gobio gobio
• 17beta-estradiol and testosterone in drainage and runoff from poultry litter applications to tilled and no-till crop land under irrigation
• 2006-2007 targeted national sewage sludge survey
• 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.
• 2008 Top 200 generic drugs by total prescriptions
• 2010 National Drug Control Strategy
• 21 C.F.R. § 211.204 Returned drug products. Code of Federal Regulations, 21 C.F.R. Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals, Subpart K: Returned and Salvaged Drug Products
• 21 C.F.R. § 211.208 Drug product salvaging. Code of Federal Regulations, 21 C.F.R. Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals, Subpart K: Returned and Salvaged Drug Products
• 3D Model of Lamprey Estrogen Receptor with Estradiol and 15?-Hydroxy-Estradiol
• 5 Chemicals That Could Contaminate Baby Formula
• 6 Best Practices for Proper Disposal of Pharmaceutical Waste
• 600: Basic Standards for All Mailing Services, 601 Mailability, section 12.12 Drugs
• 88 pollutants detected in Madrid's rivers
• 970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13
• A 19-Month-Old Girl With Recurrent Illness: Over the Hills and Through the Woods
• A Bill for an Act Relating to pharmaceutical take-back programs; appropriating money; and declaring an emergency
• A Brief Overview on the Legal Background and the Regulatory Instruments of the Environmental Risk Assessment for Pharmaceuticals in the EU, USA, Japan, Australia and Canada
• A broad spectrum analytical scheme for the screening of endocrine disruptors (EDs), pharmaceuticals and personal care products in wastewaters and natural waters
• A chamber study of secondary organic aerosol formation by linalool ozonolysis
• A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health
• A Closer Look at Fatal Medication Errors
• A Closer Look at Fatal Medication Errors--Reply
• A cocktail of contaminants: how mixtures of pesticides at low concentrations affect aquatic communities
• A Comparison of Growth Biomarkers for Assessing Sublethal Effects of Cadmium on a Marine Gastropod, Nassarius festivus
• A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater
• A comparison of three analytical techniques for the measurement of steroidal estrogens in environmental water samples
• A Computational Model of the Hypothalamic-Pituitary-Gonadal Axis in Male Fathead Minnows Exposed to 17a-Ethinylestradiol and 17b-estradiol
• A conceptual model describing the fate of sulfadiazine and its metabolites observed in manure-amended soils
• A conceptual model for assessing risks in a Mediterranean Natura 2000 Network site
• A continuous collection system pharmaceutical wastes: A pilot for household project
• A county lockup for unwanted pills
• A data based perspective on the environmental risk assessment of human pharamaceuticals II - Aquatic risk characterisation
• A data based perspective on the environmental risk assessment of human pharmaceuticals III - Indirect human exposure
• A data-based perspective on the environmental risk assessment of human pharmaceuticals I - Collation of available ecotoxicity data
• A data-based perspective on the environmental risk assessment of human pharmaceuticals I—Collation of available ecotoxicity data
• A framework for assessing the hazard of pharmaceutical materials to aquatic species
• A framework for prioritizing fragrance materials for aquatic risk assessment
• A Hard Pill to Swallow: Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements
• A harmless method for determining trenbolone acetate together with 17?-trenbolone in beef
• A Healthy Future - Pharmaceuticals in a Sustainable Society
• A Holistic Strategy for Characterizing the Safety of Metabolites through Drug Discovery and Development
• A Human Health Risk Assessment of Pharmaceuticals in the Aquatic Environment
• A Measure of Resistance: Detecting Tamiflu Metabolite in Sewage Discharge and River Water
• A Mechanistic Study on the Phototoxicity of Atorvastatin: Singlet Oxygen Generation by a Phenanthrene-like Photoproduct
• A method to include the environmental hazard in drug prescribing
• A Microtiter-Plate Based Cytochrome P4503A Activity Assay in Fish Cell Lines
• A multi-biomarker assessment of the impact of the antibacterial trimethoprim on the non-target organism Zebra mussel (Dreissena polymorpha)
• A multidimensional high performance liquid chromatography method coupled with amperometric detection using a boron-doped diamond electrode for the simultaneous determination of sulfamethoxazole and trimethoprim in bovine milk
• A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States -- II) Untreated drinking water sources
• A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States -- I) Groundwater
• A national risk assessment for intersex in fish arising from steroid estrogens
• A new concept for the environmental risk assessment of poorly water-soluble compounds and its application to consumer products
• A new gas chromatography/mass spectrometry method for the simultaneous analysis of target and non-target organic contaminants in waters
• A new induction period based reaction rate method for determination trace amounts of phenylhydrazine in water samples
• A New Planning and Design Paradigm to Achieve Sustainable Resource Recovery from Wastewater
• A new sample preparation method for determination of acidic drugs in sewage sludge applying microwave assisted solvent extraction followed by gas chromatography-mass spectrometry
• A perspective on testing of existing pharmaceutical excipients for genotoxic impurities
• A Pharmacy Runs Through It
• A political instrument to reduce the environmental impact of pharmaceuticals
• A Preliminary Canadian Environmental Emissions Inventory for Endogenous and Retail Pharmaceutical Estrogens
• A Preliminary Investigation on the Occurrence and Distribution of Antibiotics in the Yellow River and its Tributaries, China
• A Preliminary Study on the Occurrence of Cytostatic Drugs in Hospital Effluents in Beijing, China
• A QSAR Model for Predicting Rejection of Emerging Contaminants (pharmaceuticals, endocrine disruptors) by Nanofiltration Membranes
• A QSAR-like Analysis of the Adsorption of Endocrine Disruptors, Pharmaceuticals, and Personal Care Products on Modified Activated Carbons
• A review of phytoestrogens: Their occurrence and fate in the environment
• A review of the effects of emerging contaminants in wastewater and options for their removal
• A review of the endocrine activity of parabens and implications for potential risks to human health
• A review of the industrial ecology of particulate pharmaceuticals and waste minimization approaches
• A seasonal study of the mecA gene and Staphylococcus aureus including methicillin-resistant S. aureus in a municipal wastewater treatment plant
• A stash in every flush
• A Steep Increase in Domestic Fatal Medication Errors With Use of Alcohol and/or Street Drugs
• A theoretical estimation of the concentration of steroid estrogens in effluents released from municipal sewage treatment plants into aquatic ecosystems of central-southern Chile
• A Tool to Prioritize Contaminants of Emerging Concern
• A UV-transparent passive concentrator/spectrum deconvolution method for simultaneous detection of endocrine disrupting chemicals (EDCs) and related contaminants in natural waters
• A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1
• A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 2
• A vital step in managing pharmaceutical waste
• A vital step in managing pharmaceutical waste
• A voluntary environmental classification system for pharmaceutical substances
• Ab Initio and In Situ Comparison of Organic Wastewater Compounds as Indicators of Sewage-derived Microbes in Surface Waters
• Abamectin in the aquatic environment
• Abatement of ibuprofen by solar photocatalysis process: Enhancement and scale up
• Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor
• Abiotic oxidation of 17b-estradiol by soil manganese oxides
• About the environment and pharmaceuticals – a collaboration between the Department of the Environment and the Department of Drug Management and Informatics
• Accidental Methadone Ingestion in an Infant: Case Report and Review of the Literature
• Acclimation to ultraviolet irradiation affects UV-B sensitivity of Daphnia magna to several environmental toxicants
• Accumulation and disposal of leftover medications: A key aspect of pharmEcovigilance
• Accumulation of endocrine disrupting compounds in sheep fetal and maternal liver tissue following exposure to pastures treated with sewage sludge
• Accumulation of oxytetracycline and norfloxacin from saline soil by soybeans
• Accumulation of Tetracycline Resistance Genes in Aquatic Biofilms Due to Periodic Waste Loadings from Swine Lagoons
• Accumulation, Subcellular Distribution and Toxicity of Copper in Earthworm (Eisenia fetida) in the Presence of Ciprofloxacin
• Accurate mass screening and identification of emerging contaminants in environmental samples by liquid chromatography-hybrid linear ion trap Orbitrap mass spectrometry
• Acetylcholinesterase activity as a biomarker of exposure to antibiotics and pesticides in the black tiger shrimp (Penaeus monodon)
• Active Drug Ingredients, Antibiotics, and X-Ray Contrast Agents in Sewage Discharges and Surface Waters in Saxony
• Actor modelling and its contribution to the development of integrative strategies for management of pharmaceuticals in drinking water
• Acute and chronic toxicity of veterinary antibiotics to Daphnia magna
• Acute Effects of the Antibiotic Oxytetracycline on the Bacterial Community of the Grass Shrimp, Palaemonetes pugio
• Acute intentional and accidental poisoning with medications in a southern Brazilian city [Intoxicações medicamentosas agudas intencionais e não intencionais notificadas em município do Sul do Brasil]
• Acute sensitivity of activated sludge bacteria to erythromycin
• Acute toxicity of parabens and their chlorinated by-products with Daphnia magna and Vibrio fischeri bioassays
• Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes)
• Acute toxicity to freshwater organisms of antiparasitic drugs for veterinary use
• Ad hoc and Fast Forward: The Science of Hormesis Growth and Development
• Addressing safety issues of health care personnel, family members, and the environment
• ADME Boxes
• Adsorption and Degradation of Ketoprofen in Soils
• Adsorption and Degradation of Triclosan and Triclocarban in Soils and Biosolids-Amended Soils
• Adsorption and Desorption of Oxytetracycline and Carbamazepine by Multiwalled Carbon Nanotubes
• Adsorption and transformation of selected human-used macrolide antibacterial agents with iron(III) and manganese(IV) oxides
• Adsorption behavior of EE2 (17?-Ethinylestradiol) onto the inactivated sewage sludge: kinetics, thermodynamics and influence factors
• Adsorption Characteristics of Sulfamethoxazole and Metronidazole on Activated Carbon
• Adsorption of Pharmaceutical Antibiotics on Template-Synthesized Ordered Micro- and Mesoporous Carbons
• Adsorption of Selected Pharmaceuticals and an Endocrine Disrupting Compound by Granular Activated Carbon. 1. Adsorption Capacity and Kinetics
• Adsorption of Selected Pharmaceuticals and an Endocrine Disrupting Compound by Granular Activated Carbon. 2. Model Prediction
• Adsorption of tetracycline on La-impregnated MCM-41 materials
• Adsorptive Removal of Selected Pharmaceuticals by Mesoporous Silica SBA-15
• Advance Notice of Methodological Changes for Calendar Year (CY) 2011 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2011 Call Letter. Section 1, New Policy, Part D, I. Part D Benefits: Encouragement of Sponsor Practices to Curb Waste of Unused Drugs Dispensed in the Retail Setting
• Advanced fluorescence in situ hybridization to localize and quantify gene expression in japanese medaka (oryzias latipes) exposed to endocrine-disrupting compounds
• Advanced treatment of a complex pharmaceutical wastewater by nanofiltration: Membrane foulant identification and cleaning
• Advances in the determination of degradation intermediates of personal care products in environmental matrixes: a review
• Adverse effects of enrofloxacin when associated with environmental stress in Tra catfish (Pangasianodon hypophthalmus)
• Adverse effects of erythromycin on the structure and chemistry of activated sludge
• Adverse Event Reporting System (AERS)
• Advice to vultures: Avoid Spanish livestock
• Aerobic degradation of bisphenol A by Achromobacter xylosoxidans strain B-16 isolated from compost leachate of municipal solid waste
• Agrichemicals in Nebraska, USA Watersheds: Occurrence and Endocrine Effects
• Albany Medical Center Pharmaceutical waste management: A 2 year pilot project (funded under EPA Grant #X9-97256506-0)
• Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan
• Alternative Strategies for Addressing the Presence and Effects of Pharmaceutical and Personal Care Products in Freshwater Resources
• Ambient air quality and drug aftermaths of the Notte Bianca (White Night) holidays in Rome
• AMENDMENT TO THE AMENDMENT IN THE NATURE OF A SUBSTITUTE TO H.R. 5320 OFFERED BY MS. BALDWIN OF WISCONSIN: PRESENCE OF PHARMACEUTICALS AND PERSONAL CARE PRODUCTS IN SOURCES OF DRINKING WATER
• Amendment to the Universal Waste Rule: Addition of Pharmaceuticals [excerpts]
• American Chemical Society hosts briefing on pharmaceuticals in water
• American Roulette — Contaminated Dietary Supplements
• America's Most Medicated States: Prescription drug rates are highest in places where preventable chronic diseases are the norm
• An Accurate-Mass-Based Spectral-Averaging Isotope-Pattern-Filtering Algorithm for Extraction of Drug Metabolites Possessing a Distinct Isotope Pattern from LC-MS Data
• An Act relating to health - requiring the State Board of Pharmacy to establish the Cancer Drug Donation Program
• An Act To Encourage the Proper Disposal of Unused Pharmaceuticals
• An affordable method for the simultaneous determination of the most studied pharmaceutical compounds as wastewater and surface water pollutants
• An analytical procedure for the determination of different therapeutic drugs in surface waters
• An AP Investigation: Pharmaceuticals Found in Drinking Water
• An Approach to Using Toxicogenomic Data in U.S. EPA Human Health Risk Assessments: A Dibutyl Phthalate (DBP) Case Study (External Review Draft)
• An Assessment of Potential Exposure and Risk from Estrogens in Drinking Water
• An ecological risk assessment for triclosan in the terrestrial environment
• An Ecological Risk Assessment Framework for Effects of Onsite Wastewater Treatment Systems and Other Localized Sources of Nutrients on Aquatic Ecosystems
• An endocrine disrupting chemical changes courtship and parental care in the sand goby
• An environmental risk assessment for oseltamivir (Tamiflu®) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions
• An Evaluation of a Pilot-Scale Nonthermal Plasma Advanced Oxidation Process for Trace Organic Compound Degradation
• An evolution in medical waste treatment and repurposing that creates a new resource! Introducing PELLA-DRXTM
• An improved method for the simultaneous analysis of phenolic and steroidal estrogens in water and sediment
• An in vitro biomarker approach for the evaluation of the ecotoxicity of non-steroidal anti-inflammatory drugs (NSAIDs)
• An indispensable asset at risk: Merits and needs of chemicals-related environmental sciences
• An industry blowing smoke: 10 Reasons Why Gasification, Pyrolysis & Plasma Incineration are Not “Green Solutions”
• An in-situ study of the impacts of urban wastewater on the immune and reproductive systems of the freshwater mussel Elliptio complanata
• An integrated assessment of estrogenic contamination and biological effects in the aquatic environment of The Netherlands
• An international conference on "Pharmaceuticals in the Environment" in a frame of EU Knappe project
• An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata
• An overview of analytical methodologies for the determination of antibiotics in environmental waters
• An overview of arisings and large-scale treatment technologies for healthcare waste in the United Kingdom
• An overview of pharmaceuticals and personal care products contamination along the river Somes watershed, Romania
• An overview of sample preparation procedures for LC-MS multiclass antibiotic determination in environmental and food samples
• Analyses of tissues of eight marine species from Atlantic and Pacific coasts for dioxin-like chlorobiphenyls (CBs) and total CBs
• Analysis and occurrence of seven artificial sweeteners in German waste water and surface water and in soil aquifer treatment (SAT)
• Analysis and removal of emerging contaminants in wastewater and drinking water
• Analysis of 70 Environmental Protection Agency Priority Pharmaceuticals in Water by EPA Method 1694
• Analysis of amphetamine and methamphetamine as emerging pollutants in wastewater and wastewater-impacted streams
• Analysis of drugs and personal care products in French source and drinking waters: the analytical challenge and examples of application
• Analysis of drugs of abuse in wastewater by hydrophilic interaction liquid chromatography-tandem mass spectrometry
• Analysis of emerging contaminants in sewage effluent and river water: Comparison between spot and passive sampling
• Analysis of endocrine disrupting chemicals and pharmaceuticals and personal care products in water
• Analysis of endocrine disrupting compounds in wastewater and drinking water treatment plants at the nanogram per litre level
• Analysis of endocrine disrupting steroids: Investigation of their release into the environment and their behavior during bank filtration
• Analysis of environmental endocrine disrupting chemicals using the E-screen method and stir bar sorptive extraction in wastewater treatment plant effluents
• Analysis of hormone antagonists in clinical and municipal wastewater by isotopic dilution liquid chromatography tandem mass spectrometry
• Analysis of Medications Returned to Community Pharmacies
• Analysis of musk fragrances in environmental samples
• Analysis of Nine NSAIDs in Ungulate Tissues Available to Critically Endangered Vultures in India
• Analysis of Pharmaceuticals as Environmental Contaminants - Analysis of iodinated X-ray contrast media
• Analysis of Pharmaceuticals as Environmental Contaminants - Analysis of neutral and acidic pharamaceuticals by liquid chromatography mass spectrometry
• Analysis of Pharmaceuticals as Environmental Contaminants - Analysis of steroid estrogens in the environment
• Analysis of Pharmaceuticals as Environmental Contaminants - Application of bioassays/biosensors for the analysis of pharmaceuticals in environmental samples
• Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography-tandem mass spectrometry
• Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor
• Analysis of phytoestrogens, progestogens and estrogens in environmental waters from Rio de Janeiro (Brazil)
• Analysis of selected emerging contaminants in sewage sludge
• Analysis of Selected Pharmaceutical Compounds and Endocrine Disruptors in Municipal Wastewater Using Solid-Phase Microextraction and Gas Chromatography
• Analysis of Semivolatile Pharmaceuticals and Pollutants in Organic Micro Extracts Using Hot Cell Membrane Inlet Mass Spectrometry
• Analysis of Steroid Hormones in a Typical Dairy Waste Disposal System
• Analysis of sulfonamide and quinolone antibiotic residues in Korean milk using microbial assays and high performance liquid chromatography
• Analysis of sulfonamides in environmental water samples based on magnetic mixed hemimicelles solid-phase extraction coupled with HPLC-UV detection
• Analysis of the Oregon Stakeholder Drug Take Back Public Policy Process to Reduce Pharmaceutical Pollution in Oregon’s Water Resources
• Analysis of Triclocarban in Aquatic Samples by Liquid Chromatography Electrospray Ionization Mass Spectrometry
• Analysis of veterinary antibiotic residues in swine wastewater and environmental water samples using optimized SPE-LC/MS/MS
• Analysis, fate and effects of the antibiotic sulfadiazine in soil ecosystems
• Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle, 50
• Analysis, Fate, and Removal of Pharmaceuticals in the Water Cycle
• Analysis: Increasing amounts of prescription drugs are showing up in America's lakes and rivers
• Analytical approach for monitoring endocrine-disrupting compounds in urban waste water treatment plants
• Analytical Challenges and Recent Advances in the Determination of Estrogens in Water Environments
• Analytical Chemistry for Mapping Trends of Pharmaceutical and Personal Care Product Pollution from Personal Use: Some Current Research and Future Needs
• Analytical methodologies for the detection of b-lactam antibiotics in milk and feed samples
• Analytical methods for the determination of persistent ingredients of personal care products in environmental matrices
• Analytical methods for tracing pharmaceutical residues in water and wastewater
• Analytical strategies for assessing ionophores in the environment
• Analytical Testing for 1,4-Dioxane
• Analyzing transformation products of synthetic chemicals
• Annex II: List of substances which must not form part of the composition of cosmetic products
• Annexe II Part 1: List of substances which must not form part of the composition of cosmetic products
• Annual Returned Drug Report
• Another livestock drug endangers vultures: Potential replacement for bird-killing veterinary NSAID turns out to be toxic too
• Another water department’s discussion of PPCP’s
• AnSBBR applied to the treatment of wastewater from a personal care industry: Effect of organic load and fill time
• Antibiotic removal from water: Elimination of amoxicillin and ampicillin by microscale and nanoscale iron particles
• Antibiotic resistance bacteria in animals
• Antibiotic resistance in coagulase negative staphylococci isolated from wastewater and drinking water
• Antibiotic resistance of E. coli in sewage and sludge
• Antibiotic Resistance of Gram-Negative Bacteria in Rivers, United States
• Antibiotic Resistance: An Ecological Perspective on an Old Problem
• Antibiotic use in farm animals needs some regulation, USDA says
• Antibiotic-resistance profile in environmental bacteria isolated from penicillin production wastewater treatment plant and the receiving river
• Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge
• Antibiotic-resistant Escherichia coli in wastewaters, surface waters, and oysters from an urban riverine system
• Antibiotics and antibiotic resistance in water environments
• Antibiotics and antibiotic-resistant bacteria in water: Something to worry about?
• Antibiotics as a chemical stressor affecting an aquatic decomposer–detritivore system
• Antibiotics in food and environmental samples
• Antibiotics in nature: Beyond biological warfare
• Antibiotics in the aquatic environment - A review - Part I
• Antibiotics in the aquatic environment - A review - Part II
• Antibiotics in the food chain: their impact on the consumer
• Antibiotics in the Hong Kong metropolitan area: Ubiquitous distribution and fate in Victoria Harbour
• Antibiotics pose concern for ethanol producers
• Antidepressant Pharmaceuticals in Two U.S. Effluent-Impacted Streams: Occurrence and Fate in Water and Sediment, and Selective Uptake in Fish Neural Tissue
• Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed
• Antidepressants at Environmentally Relevant Concentrations Affect Predator Avoidance Behavior of Larval Fathead Minnows (Pimephales promelas)
• Antidepressants make for sad fish
• Anti-inflammatory and analgesic drugs in WWTP influent and effluent streams and the occurrence in the aquatic environment
• Antimicrobial Testing Program
• Antimicrobials and Antibacterials
• Antiviral Drugs in Wastewater and Surface Waters: A New Pharmaceutical Class of Environmental Relevance?
• AP Enterprise: Feds mull regulating drugs in water
• AP Water Probe Prompts Senate Hearings
• Application of advanced oxidation processes for removing salicylic acid from synthetic wastewaters
• Application of an easily water-compatible hypercrosslinked polymeric adsorbent for efficient removal of catechol and resorcinol in aqueous solution
• Application of chemometric assisted dispersive liquid-liquid microextraction to the determination of personal care products in natural waters
• Application of combined physicochemical and biological processes for enhanced treatment of avermectin fermentation wastewater
• Application of dispersive liquid-liquid microextraction and dispersive micro solid-phase extraction for the determination of quinolones in swine muscle by high-performance liquid chromatography with diode-array detection
• Application of dynamic liquid-phase microextraction and injection port derivatization combined with gas chromatography-mass spectrometry to the determination of acidic pharmaceutically-active compounds in water samples
• Application of passive sampling devices for screening of micro-pollutants in marine aquaculture using LC-MS/MS
• Application of Photo-Fenton as a Tertiary Treatment of Emerging Contaminants in Municipal Wastewater
• Application of Solid-Phase Microextraction for In Vivo Laboratory and Field Sampling of Pharmaceuticals in Fish
• Application of the "threshold of toxicological concern" to derive tolerable concentrations of "non-relevant metabolites" formed from plant protection products in ground and drinking water
• Application of the combination index (CI)-isobologram equation to study the toxicological interactions of lipid regulators in two aquatic bioluminescent organisms
• Application of U.S. EPA methods to the analysis of pharmaceuticals and personal care products in the environment: Determination of clofibric acid in sewage effluent by GC-MS
• Application of Ultrasound in Pharmaceutics
• Applications of advanced oxidation processes in wastewater treatment
• Applications of LC/TOF-MS in the Environmental Field: When did it start and where is it going?
• Applying Research to Public Health Questions: Biologically Relevant Exposures
• Applying Surrogates and Indicators to Assess Removal Efficiency of Trace Organic Chemicals during Chemical Oxidation of Wastewaters
• Applying the Precautionary Principle to Consumer Household Cleaning Product Development
• Appraisal of potential environmental risks associated with human antibiotic consumption in Turkey
• Approaches for quantifying the attenuation of wastewater-derived contaminants in the aquatic environment
• Approaches to Screening for Risk from Pharmaceuticals in Drinking Water and Prioritization for Further Evaluation
• Approved Drug Products with Therapeutic Equivalence Evaluations
• Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book)
• APUA: Alliance for the Prudent Use of Antibiotics
• Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects
• Aquatic ecotoxicity of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species
• Aquatic environmental assessment of the top 25 English prescription pharmaceuticals
• Aquatic fate assessment of the polycyclic musk fragrance HHCB: Scenario and variability analysis in accordance with the EU risk assessment guidelines
• Aquatic hazard assessment of veterinary medicines
• Aquatic Life Criteria for contaminants of emerging concern
• Aquatic life criteria for contaminants of emerging concern. Part I. General challenges and recommendations
• Aquatic life: Contaminants of emerging concern
• Aquatic Non-Scents Repercussions of water pollutants that mute smell
• Aquatic photochemistry of chlorinated triclosan derivatives: potential source of polychlorodibenzo-p-dioxins
• Aquatic Photochemistry of Fluoroquinolone Antibiotics: Kinetics, Pathways, and Multivariate Effects of Main Water Constituents
• Aquatic toxicity of sertraline to Pimephales promelas at environmentally relevant surface water pH
• Aqueous photocatalytic oxidation of amoxicillin
• Are endocrine disrupting compounds a health risk in drinking water?
• Are pharmaceuticals potent environmental pollutants?: Part I: Environmental risk assessments of selected active pharmaceutical ingredients
• Are pharmaceuticals potent environmental pollutants?: Part II: Environmental risk assessments of selected pharmaceutical excipients
• Are There Other Persistent Organic Pollutants? A Challenge for Environmental Chemists
• Area Tap Water Has Traces of Medicines
• Arizona Laboratory for Emerging Contaminants
• Arlington won't identify pharmaceutical drug found in city's water
• Artificial neural network models based on QSAR for predicting rejection of neutral organic compounds by polyamide nanofiltration and reverse osmosis membranes
• Artificial sweetener makes ideal tracer
• as chromatography-mass spectrometry screening methods for select UV filters, synthetic musks, alkylphenols, an antimicrobial agent, and an insect repellent in fish
• ASCP Policy Statement on the Return and Reuse of Medications in Long-term Care Facilities
• ASEAN harmonized cosmetic regulatory scheme (AHCRS)
• Assessing environmental effects of human pharmaceuticals
• Assessing selected estrogens and xenoestrogens in Brazilian surface waters by liquid chromatography-tandem mass spectrometry
• Assessing sewer-groundwater interaction at the city scale based on individual sewer defects and marker species distributions
• Assessing the assessments: Pharmaceuticals in the environment
• Assessing the Discharge of Pharmaceuticals Along the Dutch Coast of the North Sea
• Assessing the effect of a brief educational intervention on pharmacists' and pharmacy students' attitudes and knowledge regarding medicine disposal
• Assessing the effects of fluoxetine on Physa acuta (Gastropoda, Pulmonata) and Chironomus riparius (Insecta, Diptera) using a two-species water-sediment test
• Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities
• Assessment of Groundwater Contamination Risk from Nonchemical Stressors in Wastewater
• Assessment of human exposure to Bisphenol-A, Triclosan and Tetrabromobisphenol-A through indoor dust intake in Belgium
• Assessment of Peracetic Acid Disinfected Effluents by Microbiotests
• Assessment of pharmaceutical residue levels in three Irish sewage treatment plants
• Assessment of Potential Antibiotic Contaminants in Water and Preliminary Occurrence Analysis
• Assessment of the anaerobic degradation of six active pharmaceutical ingredients
• Assessment of the antibiotic resistance effects of biocides
• Assessment of the Effect Potential of Environmental Chemicals
• Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen
• Assessment of trace organic chemical removal by a membrane bioreactor using gas chromatography-mass spectrometry and a yeast screen bioassay
• Assurance of discontinuance pursuant to executive law Section 63, Subdivision (15) Attorney General of the State of New York, Investor Protection Bureau, Environmental Protection Bureau
• ATC/DDD Index 2009
• Attenuation of two estrogen compounds in aquifer materials supplemented with sewage effluent
• Attorney General Cuomo Announces Groundbreaking Settlements to Stop 5 Healthcare Facilities from Disposing of Pharmaceutical Wastes into the NYC Watershed
• Auspex Pharmaceuticals: Deuterated therapeturics in pipeline
• Automation of Reports and Consolidated Orders System
• Avaluació del risc ambiental dels productes farmacèutics en l’àmbit Català [Environmental risk assessment of pharamaceuticals in Catalan]
• Bacteria Interfere With Painkillers: Gut microbes manipulate acetaminophen metabolism
• Bacterial tolerances to metals and antibiotics in metal-contaminated and reference streams
• Bag-SPE—a convenient extraction method for screening of pharmaceutical residues in influent and effluent water from sewage treatment plants
• Balsa Raft Crossing the Pacific Finds Low Contaminant Levels
• Banned materials, prohibited materials & household hazardous wastes
• Batch and Bulk Removal of a Triarymethane Dye - Fast Green FCF, from Wastewater by Adsorption over Waste Materials
• Bathing and showering: Under-appreciated sources of water pollution from medicines
• Beefy hormones: New routes of exposure
• Behavior of antibiotics and antiviral drugs in sewage treatment plants and risk associated with their widespread use under pandemic condition
• Behavior of pharmaceutical drugs (human and animal health) in the environment
• Behavioral measures of environmental stressors
• Behaviour and Fluxes of Dissolved Antibiotics, Analgesics and Hormones During Flood Events in a Small Heterogeneous Catchment in the Grand Duchy of Luxembourg
• Behaviour and occurrence of estrogens in municipal sewage treatment plants -- I. Investigations in Germany, Canada and Brazil
• Behaviour and occurrence of estrogens in municipal sewage treatment plants -- II. Aerobic batch experiments with activated sludge
• Behaviour of 14C-sulfadiazine and 14C-difloxacin during manure storage
• Behaviour of selected human and veterinary pharmaceuticals in aquatic compartments and soil
• Bernie A Strain’s Testimony before the US Senate’s Special Committee on Aging at Upcoming Hearing on Prescription Drug Disposal June 30, 2010
• Best Management Practices for Unused Pharmaceuticals at Health Care Facilities - Draft for Public Comment
• Beyond Abundance: Self-Interest Motives for Sustainable Consumption in Relation to Product Perception and Preferences
• Beyond Fluoride: Pharmacenticals, Drinking Water and the Public Health
• Beyond Fluoride: Pharmaceuticals, Drinking Water and the Public Health
• Big interest in heavy drugs
• Bill calls for stricter rules on cosmetics: FDA would approve ingredients, conduct regular testing, scrutinize labels, order recalls
• Bill Status of SB1919: AN ACT concerning safety
• Bill targeting unused drugs moves ahead - State House: Drug manufacturers say the cost of medicines will increase if disposal becomes their responsibility
• Bioaccumulation of Pharmaceuticals and Other Anthropogenic Waste Indicators in Earthworms from Agricultural Soil Amended With Biosolid or Swine Manure
• Bioaccumulation of the synthetic hormone 17α-ethinylestradiol in the benthic invertebrates Chironomus tentans and Hyalella azteca
• Bioaccumulation of Triclocarban in Lumbriculus variegates
• Bioaccumulation of Triclocarban in Lumbriculus variegatus
• Bioactivity-based screening of antibiotics and hormones
• Bioanalytical characterisation of multiple endocrine- and dioxin-like activities in sediments from reference and impacted small rivers
• Biodegradability of pharmaceutical industrial wastewater and formation of recalcitrant organic compounds during aerobic biological treatment
• Biodegradation and Biosorption of tetracycline and tylosin antibiotics in activated sludge system
• Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review
• Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review
• Biodegradation by activated sludge and toxicity of tetracycline into a semi-industrial membrane bioreactor
• Biodegradation of 17 beta-estradiol, Estrone and Testosterone in Stream Sediments
• Biodegradation of 17ß-estradiol, Estrone and Testosterone in Stream Sediments
• Biodegradation of endocrine disrupting compounds in harbour seawater and sediments
• Biodegradation of endocrine-disrupting compounds and suppression of estrogenic activity by ligninolytic fungi
• Biodegradation of Pharmaceutical and Personal Care Products
• Biodegradation of pharmaceutical residues investigated by SPE-GC/ITD-MS and on-line derivatization
• Biodegradation of pharmaceuticals
• Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism
• Biodegradation of the analgesic naproxen by Trametes versicolor and identification of intermediates using HPLC-DAD-MS and NMR
• Biodegradation of trace pharmaceutical substances in wastewater by a membrane bioreactor
• Biodegradation potential of wastewater micropollutants by ammonia-oxidizing bacteria
• Biological and physical attenuation of endocrine disruptors and pharmaceuticals: Implications for water reuse
• Biological effects of anthropogenic contaminants in the San Francisco Estuary
• Biological removal of 17α-ethinylestradiol by a nitrifier enrichment culture in a membrane bioreactor
• Biological removal of 17a-ethinylestradiol (EE2) in an aerated nitrifying fixed bed reactor during ammonium starvation
• Biomonitoring Hospital Effluents by the Allium cepa L. Test
• Biosensors for the Environmental Monitoring of Aquatic Systems: Bioanalytical and Chemical Methods for Endocrine Disruptors
• Biosolids Applied to Land: Advancing Standards and Practices
• Biosolids Tracking Efforts a Jumble of Research With No Clear Answers
• Biotransformation of estrogens and synthetic pharmaceuticals and personal care products in a sandy loam soil
• Biotransformation of the Polycyclic Musks HHCB and AHTN and Metabolite Formation by Fungi Occurring in Freshwater Environments
• Birth control for breakfast, anyone? - Brief Article
• Book review: Insights 9 - Assessing Illicit Drugs in Wastewater: Potential and limitations of a new monitoring approach
• Book Review: Thomas Ternes and Adriano Joss, Editors, Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management, [IWA Publishing (2006) ISBN 1843390930 468 pp]
• Boston pee party
• Bottled Water Safe from Pharmaceutical Contaminants
• Bottlemania: How water went on sale and why we bought it
• Breaking the voodoo spell
• Bridging fate, exposure, and ecotoxicity of contaminants
• Bridging Levels of Pharmaceuticals in River Water with Biological Community Structure in the Llobregat River Basin (NE Spain)
• Buying Medicines Over the Internet
• Cabinet Confidential: Toxic Products in the Home
• Caffeine in Boston Harbor seawater
• California Department of Toxic Substances Control Presents Symposium on Effects of Pharmaceuticals and Personal Care Products in the Environment
• California Senate SB 416 (Florez) Antibiotics
• Call to Action: Drugs in Our Water
• Can aquatic distribution of human pharmaceuticals be related to pharmacological data?
• Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium
• Can Drug Delivery Be A Solution to the Pharmaceuticals In the Environment Problem?
• Canada Scrutinizes Drugs in Water
• Cancers from Environment 'Grossly Underestimated': Daily Exposures Cause Far More Cancers Than Once Thought, a Presidential Panel Says
• Carbamazepine, diclofenac, ibuprofen and bezafibrate - investigations on the behaviour of selected pharmaceuticals during wastewater treatment,
• Carrier mediated hollow fiber liquid phase microextraction combined with HPLC-UV for preconcentration and determination of some tetracycline antibiotics
• Case histories in pharmaceutical risk management
• Catalysts to improve the abatement of sulfamethoxazole and the resulting organic carbon in water during ozonation
• Catalytic Ozonation of Selected Pharmaceuticals over Mesoporous Alumina-Supported Manganese Oxide
• Cation Binding of Antimicrobial Sulfathiazole to Leonardite Humic Acid
• Cellular and humoral immunodepression in vultures feeding upon medicated livestock carrion
• Cellular effect evaluation of micropollutants using transporter functions of renal proximal tubule cells
• Centre For Control of Emerging Contaminants: CCEC
• Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry
• Challenges in current adult fish laboratory reproductive tests: suggestions for refinement using a mummichog (Fundulus heteroclitus) case study
• Changes in Reproductive Biomarkers in an Endangered Fish Species (Bonytail Chub, Gila elegans) Exposed to Low Levels of Organic Wastewater Compounds in a Controlled Experiment
• Changes in the relative expression pattern of multiple vitellogenin genes in adult male and larval zebrafish exposed to exogenous estrogens
• Chapter 3 Biodegradation of Pharmaceutical and Personal Care Products
• Characterization of benzothiazoles, benzotriazoles and benzosulfonamides in aqueous matrixes by solid-phase extraction followed by comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry
• Characterization of environmental estrogens in river water using a three pronged approach: active and passive water sampling and the analysis of accumulated estrogens in the bile of caged fish
• Characterization of medical waste from hospitals in Tabriz, Iran
• Characterization of Metabolites Formed During the Biotransformation of 17a-Ethinylestradiol by Nitrosomonas europaea in Batch and Continuous Flow Bioreactors
• Characterization of new nitrosamines in drinking water using liquid chromatography tandem mass spectrometry
• Characterization of Route Specific Impurities Found in Methamphetamine Synthesized by the Leuckart and Reductive Amination Methods
• Characterization of the Degradation Performance of the Sulfamethazine Antibiotic by Photo-Fenton Process
• Characterizing and Compensating for Matrix Effects Using Atmospheric Pressure Chemical Ionization Liquid Chromatography-Tandem Mass Spectrometry: Analysis of Neutral Pharmaceuticals in Municipal Wastewater
• Characterizing the passage of personal care products through wastewater treatment processes,
• Characterizing the Potential Human Toxicity from Low Doses of Pharmaceuticals in Drinking Water: Are New Risk Assessment Methods or Approaches Require?
• Chemical and biological analysis of endocrine disrupting hormones and estrogenic activity in an advanced sewage treatment plant
• Chemical and biological analysis of estrogenic, progestagenic and androgenic steroids in the environment
• Chemical and Biological Characterization of Estrogenicity in Effluents from WWTPs in Ria de Aveiro (NW Portugal)
• Chemical evaluation of contaminants in wastewater effluents and the environmental risk of reusing effluents in agriculture
• Chemical Hydrophobicity and Uptake by Plant Roots
• Chemical mixtures program
• Chemicals from pharmaceuticals and personal care products
• Chemicals from the Practice of Healthcare: Challenges and Unknowns Posed by Residues in the Environment
• Chemicals in the European Environment: Low Doses, High Stakes?
• Chemicals leach from packaging
• Chemicals of High Concern List
• Chemicals Remain in Most Treated Water, Says Report
• Chemometric tools improving the determination of anti-inflammatory and antiepileptic drugs in river and wastewater by solid-phase microextraction and liquid chromatography diode array detection
• ChemPortal: The Global Portal to Information on Chemical Substances
• Chicago Police Open Drop Boxes for Unwanted Meds
• China faces new problem: Disposing of tainted milk
• Chiral Analysis of Ibuprofen Residues in Water and Sediment
• Chiral Toxicology: It's the Same Thing...Only Different
• Chromatophore
• Chronic aquatic environmental risks from exposure to human pharmaceuticals
• Chronic Effects Assessment and Plasma Concentrations of the b-blocker Propranolol in Fathead Minnows (Pimephales promelas)
• Cilia-driven rotational behavior in gastropod (Physa elleptica) embroys induced by serotonin and putative serotonin reuptake inhibitors (SSRIs)
• Ciprofloxacin in Hospital Effluent: Degradation by Ozone and Photoprocesses
• Ciprofloxacin ozonation in hospital wastewater treatment plant effluent: Effect of pH and H2O2
• Ciprofloxacin Resistance in Domestic Wastewater Treatment Plants
• Ciprofloxacin sorption by dissolved organic carbon from reference and bio-waste materials
• Clean out your medicine cabinet: Today!
• Clinical Research Guidelines on Environmental Pharmacology
• Clofibric acid degradation in UV254/H2O2 process: effect of temperature
• Clotrimazole exposure modulates aromatase activity in gonads, brain during gonadal differentiation in Xenopus tropicalis frogs
• CMS Proposes "Trial Sizes" Of Prescriptions To Curb Waste Of Unused Drugs In Part D
• CMS Proposes "Trial Sizes" Of Prescriptions To Curb Waste Of Unused Drugs In Part D
• Coadsorption of Ciprofloxacin and Cu(II) on Montmorillonite and Kaolinite as Affected by Solution pH
• Coastal sewage discharge and its impact on fish with reference to antibiotic resistant enteric bacteria and enteric pathogens as bio-indicators of pollution
• Cocaine and heroin in waste water plants: A 1-year study in the city of Florence, Italy
• Cocaine and metabolites in waste and surface water across Belgium
• Cocaine Contaminates Majority of U.S. Currency
• Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse
• Cocaine on Money: Drug Found on 90% of U.S. Bills
• Cocaine, Spices, Hormones Found in Drinking Water
• Colloids as a sink for certain pharmaceuticals in the aquatic environment
• Combination of in vitro bioassays for the determination of cytotoxic and genotoxic potential of wastewater, surface water and drinking water samples
• Combination Of Off-Line Solid-Phase Extraction And On-Column Sample Stacking For Sensitive Determination Of Parabens And P-Hydroxybenzoic Acid In Waters By Non-Aqueous Capillary Electrophoresis
• Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environment
• Combined electrocoagulation and TiO2 photoassisted treatment applied to wastewater effluents from pharmaceutical and cosmetic industries
• Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe
• Combined UF-NF membrane system for filtering erythromycin fermentation broth and concentrating the filtrate to improve the downstream efficiency
• Combining chemical analysis and ecotoxicity to determine environmental exposure to and to assess risk from sulfonamides
• Combining passive samplers and biomonitors to evaluate endocrine disrupting compounds in a wastewater treatment plant by LC/MS/MS and bioassay analyses
• Coming round to recycling
• Comment letter - April 15, 2010 Draft Monitoring Strategies for Chemicals of Emerging Concern (CECs) in Recycled Water: Recommendations of a Science Advisory Panel
• Comment on "Bioaccumulation of Pharmaceuticals and Other Anthropogenic Waste Indicators in Earthworms from Agricultural Soil Amended With Biosolid or Swine Manure"
• Comment on "Occurrence and Concentrations of Benzotriazole UV Stabilizers in Marine Organisms and Sediments from the Ariake Sea, Japan"
• Comment on "The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters"
• Comment on “Speciation Analysis of Gadolinium Chelates in Hospital Effluents and Wastewater Treatment Plant Sewage by a Novel HILIC/ICP-MS Method”
• Comment on Estrogen receptor agonist fate during wastewater and biosolids treatment processes: A mass balance analysis
• Comment on 'Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. Streams, 1999-2000: a national reconnaissance'
• Comment on 'Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance'
• Comment on 'Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance
• Comment to DEA regarding Drug Enforcement Agency’s Advance Notice of Proposed Rulemaking (ANPRM) seeking information on the disposal of controlled substances
• Comment to EPA regarding proposed addition of hazardous pharmaceutical wastes to the Universal Waste Rule
• COMMISSION DECISION of 19 March 2010 concerning the non-inclusion of 2,4,4’-trichloro-2’-hydroxydiphenyl ether in the Union list of additives which may be used in the manufacture of plastic materials and articles intended to come into contact with foodstuffs under Directive 2002/72/EC
• Committee on Hormonally Active Agents in the Environment, Hormonally Active Agents in the Environment
• Community responses to contaminants: using basic ecological principles to predict ecotoxicological effects
• Comparative adsorption of levodopa from aqueous solution on different activated carbons
• Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals: Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action
• Comparative Aquatic Toxicity of Propranolol and its Photodegraded Mixtures: Algae and Rotifer Screening
• Comparative assessment of genotoxicity of mineral water packed in polyethylene terephthalate (PET) and glass bottles
• Comparative life cycle assessments of incineration and non-incineration treatments for medical waste
• Comparative microscale analysis of the effects of triclosan and triclocarban on the structure and function of river biofilm communities
• Comparative study of indices used in toxicity evaluation of effluents
• Comparative toxicity assessment of ozone and activated carbon treated sewage effluents using an in vivo test battery
• Comparing steroid estrogen, and nonylphenol content across a range of European sewage plants with different treatment and management practices
• Comparing the Environmental Footprints of Home-Care and Personal-Hygiene Products: The Relevance of Different Life-Cycle Phases
• Comparing wastewater chemicals, indicator bacteria concentrations, and bacterial pathogen genes as fecal pollution indicators
• Comparison of analytical and theoretical pharmaceutical concentrations in human urine in Germany
• Comparison of different advanced oxidation processes for treatment of antibiotic aqueous solution
• Comparison of electrospray ionization and atmospheric pressure chemical ionization for multi-residue analysis of biocides, UV-filters and benzothiazoles in aqueous matrices and activated sludge by liquid chromatography - tandem mass spectrometry
• Comparison of molecularly imprinted, mixed-mode and hydrophilic balance sorbents performance in the solid-phase extraction of amphetamine drugs from wastewater samples for liquid chromatography-tandem mass spectrometry determination
• Comparison of removal of pharmaceuticals in MBR and activated sludge systems
• Comparison of six different sewage treatment processes--Reduction of estrogenic substances and effects on gene expression in exposed male fish
• Comparison of six sewage effluents treated with different treatment technologies--Population level responses in the harpacticoid copepod Nitocra spinipes
• Comparison of the ozonation and Fenton process performances for the treatment of antibiotic containing manure
• Comparison of two screening level risk assessment approaches for six disinfectants and pharmaceuticals
• Comparison of Water, Sediment and Plants for the Monitoring of Antibiotics: A Case Study on a River Dedicated to Fish Farming
• Competition between Electrochemical Advanced Oxidation and Electrochemical Hypochlorination of Sulfamethoxazole at a Boron-Doped Diamond Anode
• Complementary mass spectrometry and bioassays for evaluating pharmaceutical-transformation products in treatment of drinking water and wastewater
• Complete list of publications
• Comprehensive fast multiresidue screening of 150 veterinary drugs in milk by ultra-performance liquid chromatography coupled to time of flight mass spectrometry
• Compromise amendments 1–3: proposal for a Directive of the European Parliament and of the Council on environmental quality standards in the field of water policy and amending Directive 2000/60/EC
• Concentrations and mass loadings of hormones, alkylphenols, and alkylphenol ethoxylates in healthcare facility wastewaters
• Concentrations and mobility of human pharmaceuticals in the world's largest wastewater irrigation system, Mexico City-Mezquital Valley
• Concern of Pharmaceuticals in Drinking Water
• Concerns about pharmaceuticals in water reuse, groundwater recharge, and animal waste
• Congress Set to Reform Law on Personal Care Product Safety
• Conjugated Polyelectrolyte Capsules: Light-Activated Antimicrobial Micro "Roach Motels"
• Conjugated steroids: analytical approaches and applications
• Consequences of Treated Water Recycling as Regards Pharmaceuticals and Drugs in Surface and Ground Waters of a Medium-sized Mediterranean Catchment
• Considering User Attitude in Early Development of Environmentally Friendly Technology: A Case Study of NoMix Toilets
• Consumer giant pushes pharma angle
• Consumer Product Ingredient Communication Initiative
• Contaminant Candidate List 3 (CCL 3)
• Contaminants in the Mississippi River
• Contaminants in the Upper Mississippi River: historic trends, responses to regulatory controls, and emerging concerns
• Contaminants of Emerging Concern Challenge Ecotoxicology
• Contaminants of Emerging Concern: Introduction to a Featured Collection
• Contamination from Pharmaceutical Disposal: Who Should Pay?
• Contamination of environment by pharmaceuticals and its connected hazards
• Contamination of surface, ground, and drinking water from pharmaceutical production
• Contamination profiles and mass loadings of select macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant
• Continuous flow hollow fiber liquid-phase microextraction and monitoring of NSAID pharmaceuticals in a sewage treatment plant effluent
• Continuous solid-phase extraction and gas chromatography-mass spectrometry determination of pharmaceuticals and hormones in water samples
• Contraceptive steroids from pharmaceutical waste perturbate junctional communication in sertoli cells
• Controlled Drug Destruction Kit
• Controversy swirls around toilet-to-tap project
• Co-Occurrence of Triclocarban and Triclosan in U.S. Water Resources
• Copepods and Ichthyoplankton: Laboratory Studies of Pharmaceutical Waste Toxicity
• Corralling steroid-laced cattle
• Corrigendum to "Effects of the antibiotic ciprofloxacin on the bacterial community structure and degradation of pyrene in marine sediment"
• Corrigendum to Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field
• Cosmetics in our aquatic environment
• Could your seafood contain toxic chemicals? Investigation reveals substances that could cause serious health issues
• Counter-flow electrokinetic supercharging for the determination of non-steroidal anti-inflammatory drugs in water samples
• County approves regional wastewater treatment plant
• Covanta Offers Free, Safe Destruction of Residents' Unwanted Drugs: Program Aims to Protect Nation's Waterways from Pharmaceutical Contamination
• Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy
• Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions
• Creating a Sustainability Culture - A (Human Resources) Management Perspective for Sustainable Pharmacy
• Criteria for Designing Sewage Treatment Plants for Enhanced Removal of Organic Micropollutants
• Critical evaluation of the determination of pharmaceuticals, personal care products, phenolic endocrine disrupters and faecal steroids by GC/MS and PTV-GC/MS in environmental waters
• Critical Review Meta-analysis of Mass Balances for Monitoring Chemical Fate during Wastewater Treatment
• Crops absorb livestock antibiotics, science shows
• Cross-species comparison of fluoxetine metabolism with fish liver microsomes
• Cyclophosphamide removal from water by nanofiltration and reverse osmosis membrane
• CYP1A inhibition in fish gill filaments: A novel assay applied on pharmaceuticals and other chemicals
• Cytotoxic and genotoxic effects of in vitro exposure to Triclosan and Trimethoprim on zebra mussel (Dreissena polymorpha) hemocytes
• Cytotoxic Drugs in Drinking Water: A Prediction and Risk Assessment Exercise for the Thames Catchment in the United Kingdom
• Daily baths and showers polluting the environment: Showers and baths are polluting water supplies partly due to growth in shampoos, gels and skin products, new research claims
• Damià Barceló, Peter-Diedrich Hansen (Eds.): Biosensors for the environmental monitoring of aquatic systems. Bioanalytical and chemical methods for endocrine disruptors
• Damming the flow of drugs into drinking water
• Dare to Keep Drugs Out of Your Drinking Water
• Data for Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000.
• De Facto of Drugs in our Drinking Water
• DEA drug take-back nets 121 tons of unwanted drugs
• Deactivation and transformation products in biodegradability testing of beta-lactams amoxicillin and piperacillin
• Debunking Some Misconceptions about Nanotoxicology
• Decay of endocrine-disrupting chemicals in aerobic and anoxic groundwater
• Decompostion of pharmaceuticals (sulfamethazine and sulfathiazole) using oxygen-based membrane biofilm reactor
• Decontamination industrial pharmaceutical wastewater by combining solar photo-Fenton and biological treatment
• Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas)
• Degradação de fármacos residuais por processos oxidativos avançados [Degradation of residual pharmaceuticals by advanced oxidation processes]
• Degradation and adsorption of selected pharmaceuticals and personal care products (PPCPs) in agricultural soils
• Degradation and depletion of pharmaceuticals in the environment
• Degradation and Ecotoxicity of the Biomedical Drug Artemisinin in Soil
• Degradation and Elimination of Various Sulfonamides during Anaerobic Fermentation: A Promising Step on the Way to Sustainable Pharmacy?
• Degradation and metabolite formation of 17[beta]-estradiol-3-sulphate in New Zealand pasture soils
• Degradation of 17 alpha-ethinylestradiol in aqueous solution by ozonation
• Degradation of 17β-estradiol and its conjugates: Effects of initial concentration and MLSS concentration
• Degradation of amoxicillin, ampicillin and cloxacillin antibiotics in aqueous solution by the UV/ZnO photocatalytic process
• Degradation of ampicillin in pig manure slurry and an aqueous ampicillin solution using electron beam irradiation
• Degradation of Antibiotic Ciprofloxacin Hydrochloride by Photo-Fenton Oxidation Process
• Degradation of biorefractory furaltadone in aqueous solution by ozonation
• Degradation of caffeine and identification of the transformation products generated by ozonation
• Degradation of DEET by ozonation in aqueous solution
• Degradation of diclofenac by TiO2 photocatalysis: UV absorbance kinetics and process evaluation through a set of toxicity bioassays
• Degradation of diclofenac during sonolysis, ozonation and their simultaneous application
• Degradation of emerging contaminants at low concentrations in MWTPs effluents with mild solar photo-Fenton and TiO2
• Degradation of fifteen emerging contaminants at [mu]g L[mu]1 initial concentrations by mild solar photo-Fenton in MWTP effluents
• Degradation of five selected endocrine-disrupting chemicals in seawater and marine sediment
• Degradation of melatonin by UV, UV/H2O2, Fe2+/H2O2 and UV/Fe2+/H2O2 processes
• Degradation of naproxen and carbamazepine in spiked sludge by slurry and solid-phase Trametes versicolor systems
• Degradation of n-butylparaben and 4-tert-octylphenol in H2O2/UV system
• Degradation of oxolinic acid and flumequine in aquaculture pond waters and sediments
• Degradation of selected pharmaceuticals in aqueous solution with UV and UV/H2O2
• Degradation of sulfamethoxazole in water by solar photo-fenton. Chemical and toxicological evaluation
• Degradation of tetracycline and oxytetracycline by crude lignin peroxidase prepared from Phanerochaete chrysosporium - A white rot fungus
• Degradation of tetracycline antibiotics: Mechanisms and kinetic studies for advanced oxidation/reduction processes
• Degradation of the antibiotics amoxicillin, ampicillin and cloxacillin in aqueous solution by the photo-Fenton process
• Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR
• Degradation of the emerging contaminant ibuprofen in water by Photo-Fenton
• Degradation of the endocrine disrupting chemicals (EDCs) carbamazepine, clofibric acid, and iopromide by corona discharge over water
• Degradation of the fluoroquinolone enrofloxacin by electrochemical advanced oxidation processes based on hydrogen peroxide electrogeneration
• Deliquescence of pharmaceutical systems
• Dental anesthetics
• DEP Says NYC Drinking Water Safe
• DEP Seeks Comments on Product Stewardship Report
• DEP Study Shows No Risk from Pharmaceuticals and Personal Care Products in NYC Drinking Water: Findings Confirm NYC Water is Safe and Healthy to Drink
• DEP Tests Show Prescription Drugs Leaching From Landfills
• Dependence of Sulfadiazine Oxidative Degradation on Physicochemical Properties of Manganese Dioxides
• Depletion of chlortetracycline during composting of aged and spiked manures
• Depletion of selective serotonin reuptake inhibitors during sewage sludge composting
• Dermal absorption of environmental contaminants from soil and sediment: a critical review
• Descriptive and mechanistic toxicity of conazole fungicides using the model test alga Dunaliella tertiolecta (chlorophyceae)
• Desk Based Review of Current Knowledge on Pharmaceuticals in Drinking Water and Estimation of Potential Levels, Final Report to Drinking Water Inspectorate
• Detection and measurement of the phamaceuticals entering Boston Harbor
• Detection of Anthropogenic Gadolinium in treated wastewater in South East Queensland, Australia
• Detection of antibiotic resistant bacteria inhabiting the sand of non-recreational marine beach
• Detection of endocrine disrupting chemicals in aerial invertebrates at sewage treatment works
• Detection of pharmaceuticals and personal care products in industrial and residential effluent wastewater
• Detection of pharmaceuticals entering Boston Harbor
• Detection of the anti-androgenic effect of endocrine disrupting environmental contaminants using in vivo and in vitro assays in the three-spined stickleback
• Detection of the Antimicrobials Triclocarban and Triclosan in Agricultural Soils following Land Application of Municipal Biosolids
• Detection of the Antiviral Drug Oseltamivir in Aquatic Environments
• Detection of Triclocarban and Two Co-Contaminating Chlorocarbanilides in U.S. Aquatic Environments Using Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry
• Determinants of hepato- and spleno-megaly in Hunan, China: cross-sectional survey data from areas endemic for schistosomiasis
• Determination and Source Apportionment of Five Classes of Steroid Hormones in Urban Rivers
• Determination of 17a-Ethynylestradiol, Carbamazepine, Diazepam, Simvastatin, and Oxybenzone in Fish Livers
• Determination of 17alpha-Ethynylestradiol, Carbamazepine, Diazepam, Simvastatin, and Oxybenzone in Fish Livers
• Determination of 19 sulfonamides in environmental water samples by automated on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry (SPE-LC-MS/MS)
• Determination of 76 Pharmaceutical Drugs by Liquid Chromatography-Tandem Mass Spectrometry in Slaughterhouse Wastewater
• Determination of airborne particle-associated benz[a]anthracene-7,12-quinone using high-performance liquid chromatography with in-line reduction and fluorescence detection
• Determination of anabolic steroids in bovine urine by liquid chromatography-tandem mass spectrometry
• Determination of antibiotics in sewage from hospitals, nursery and slaughter house, wastewater treatment plant and source water in Chongqing region of Three Gorge Reservoir in China
• Determination of anti-inflammatory drugs in water samples, by in situ derivatization, solid phase microextraction and gas chromatography-mass spectrometry
• Determination of bezafibrate, methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters using on-line solid-phase extraction liquid chromatography coupled to polarity-switching electrospray tandem mass spectrometry
• Determination of carbamazepine in aquatic organisms by liquid–liquid extraction and liquid chromatography-tandem mass spectrometry
• Determination of Drugs of Abuse in Airborne Particles by Pressurized Liquid Extraction and Liquid Chromatography-Electrospray-Tandem Mass Spectrometry
• Determination of drugs of abuse in water by solid-phase extraction, derivatisation and gas chromatography-ion trap-tandem mass spectrometry
• Determination of eight penicillin antibiotics in pharmaceuticals, milk and porcine tissues by nano-liquid chromatography
• Determination of endocrine disrupting compounds using temperature-dependent inclusion chromatography II. Fast screening of free steroids and related low-molecular-mass compounds fraction in the environmental samples derived from surface waters, treated and untreated sewage waters as well as activated sludge material
• Determination of endocrine disrupting compounds using temperature-dependent inclusion chromatography: I. Optimization of separation protocol
• Determination of endocrine-disrupting chemicals in the liquid and solid phases of activated sludge by solid phase extraction and gas chromatography-mass spectrometry
• Determination of fluoroquinolone antibiotics in environmental water samples based on magnetic molecularly imprinted polymer extraction followed by liquid chromatography-tandem mass spectrometry
• Determination of fluoroquinolones in aquaculture products by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)
• Determination of multiple pharmaceutical classes in surface and ground waters by liquid chromatography-ion trap-tandem mass spectrometry
• Determination of non-steroidal anti-inflammatory drugs in wastewaters by magnetic matrix solid phase dispersion-HPLC
• Determination of NSAIDs in river sediment samples
• Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/MS
• Determination of organic micro-pollutants such as personal care products, plasticizers and flame retardants in sludge
• Determination of personal care products in sewage sludge by pressurized liquid extraction and ultra high performance liquid chromatography-tandem mass spectrometry
• Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works
• Determination of pharmaceutical compounds in surface and ground waters in Loire-Bretagne basin
• Determination of pharmaceuticals in environmental and biological matrices using pressurised liquid extraction - are we developing sound extraction methods?
• Determination of pharmaceuticals in river water by column switching of large sample volumes and liquid chromatography-diode array detection, assisted by chemometrics: An integrated approach to green analytical methodologies
• Determination of pharmaceuticals in sewage sludge by pressurized liquid extraction (PLE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS)
• Determination of pharmaceuticals in soils and sediments by pressurized liquid extraction and liquid chromatography tandem mass spectrometry
• Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry
• Determination of polar 1H-benzotriazoles and benzothiazoles in water by solid-phase extraction and liquid chromatography LTQ FT Orbitrap mass spectrometry
• Determination of select antidepressants in fish from an effluent-dominated stream
• Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry
• Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites
• Determination of steroid sex hormones in wastewater by stir bar sorptive extraction based on poly(vinylpyridine-ethylene dimethacrylate) monolithic material, liquid chromatographic analysis
• Determination of sulfonamide residues in water samples by in-line solid-phase extraction-capillary electrophoresis
• Determination of synthetic polycyclic musks in water by microwave-assisted headspace solid-phase microextraction and gas chromatography-mass spectrometry
• Determination of tetracycline residues in soil by pressurized liquid extraction and liquid chromatography tandem mass spectrometry
• Determination of the steroid hormone levels in water samples by dispersive liquid-liquid microextraction with solidification of a floating organic drop followed by high-performance liquid chromatography
• Determination of total and free mono-n-butyl phthalate in human urine samples after medication of a di-n-butyl phthalate containing capsule
• Determination of triclosan, triclocarban and methyl-triclosan in aqueous samples by dispersive liquid-liquid microextraction combined with rapid liquid chromatography
• Determination of Trimethylbismuth in the Human Body after Ingestion of Colloidal Bismuth Subcitrate
• Determination of widely used non-steroidal anti-inflammatory drugs in water samples by in situ derivatization, continuous hollow fiber liquid-phase microextraction and gas chromatography-flame ionization detector
• Determining the fraction of pharmaceutical residues in wastewater originating from a hospital
• Developing Drug Repository Programs Raise Concerns, Boards of Pharmacy Contribute Expertise in Creation of Regulations
• Development and characterization of an amperometric sensor for triclosan detection based on electropolymerized molecularly imprinted polymer
• Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line
• Development and validation of a rapid method for the determination of tetracycline in activated sludge by SPE clean-up and HPLC-UV detection
• Development and validation of a sensitive and selective method using GC/MS-MS for quantification of 5-fluorouracil in hospital wastewater
• Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine
• Development document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing point source category, Office of Water
• Development of a Biomimetic Enzyme-Linked Immunosorbent Assay Method for the Determination of Estrone in Environmental Water using Novel Molecularly Imprinted Films of Controlled Thickness as Artificial Antibodies
• Development of a comprehensive LC/MS/MS method for the detection of cocaine and other illicit drugs in municipal wastewater
• Development of a highly sensitive, second antibody format chemiluminescence enzyme immunoassay for the determination of 17[beta]-estradiol in wastewater
• Development of a micro-plate magnetic chemiluminescence enzyme immunoassay (MMCLEIA) for rapid- and high-throughput analysis of 17?-estradiol in water samples
• Development of a molecular biomarker system using proteomics on lymphocyte culture to assess the use of drugs and chemicals in Pangasianodon hypophthalmus aquaculture
• Development of a new scale to measure self-reported medication nonadherence
• Development of advanced treatment trains and decision support tools to meet future drinking water challenges
• Development of an ultra-high-pressure liquid chromatography-tandem mass spectrometry multi-residue sulfonamide method and its application to water, manure slurry, and soils from swine rearing facilities
• Development of biomarkers of stress related to endocrine disruption in gastropods: Alkali-labile phosphates, protein-bound lipids and vitellogenin-like proteins
• Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants
• Development of immunoassays to determinate sulfamethoxazole residues in wastewaters
• Development of Indicators and Surrogates for Chemical Contaminant Removal during Wastewater Treatment and Reclamation Phase II
• Development of sulfamethoxazole-imprinted polymers for the selective extraction from waters
• Development, validation and implementation of a receptor based bioassay capable of detecting a broad range of beta-agonist drugs in animal feedingstuffs
• Developmental anomalies induced by a non-selective COX inhibitor (Ibuprofen) in zebrafish, (Danio rerio)
• Developmental Effects of a Municipal Wastewater Effluent on Two Generations of the Fathead Minnow, Pimephales promelas
• Developmental Synergism of Steroidal Estrogens in Sex Determination
• Diclofenac removal from water with ozone and activated carbon
• Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction
• Diclofenac-enriched artificial sediment induces oxidative stress in Hyalella azteca
• Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol.
• Diffuse pollution of surface water by pharmaceutical products
• Dilemmas facing regulatory and advisory bodies dealing with conflicting results
• Direct Analysis of Volatile Methylsiloxanes in Gaseous Matrixes Using Atmospheric Pressure Chemical Ionization-Tandem Mass Spectrometry
• Direct Effects, Compensation, and Recovery in Female Fathead Minnows Exposed to a Model Aromatase Inhibitor
• Direct UV photolysis of propranolol and metronidazole in aqueous solution
• Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
• Discussion Document on Eco-pharmavigilance
• Discussion on the application of UV/H(2)O(2), O(3) and O(3)/UV processes as technologies for sewage reuse considering the removal of pharmaceuticals and personal care products
• Disinfection by-products and other emerging contaminants in drinking water
• Disinfection By-Products of para-Hydroxybenzoate Esters (Parabens): Synthesis and Mass Spectrometric Study
• Dispensing of Controlled Substances to Residents at Long Term Care Facilities
• Dispersive liquid-liquid microextraction applied to the simultaneous derivatization and concentration of triclosan and methyltriclosan in water samples
• Dispersive solid-phase microextraction method for sample extraction in the analysis of four tetracyclines in water and milk samples by high-performance liquid chromatography with diode-array detection
• Disposal as a Source of Pharmaceuticals in the Environment
• Disposal by Flushing of Certain Unused Medicines: What You Should Know
• Disposal of Controlled Substances
• Disposal of Controlled Substances by Persons Not Registered With the Drug Enforcement Administration
• Disposal of Hazardous Pharmaceutical Waste
• Disposal of Pharmaceutical Waste in Households - A European Survey
• Disposal of unused medicines-Concern grows over environmental impacts
• Disposal of Unwanted Medicines through Pharmacies (DUMP)
• Disposal of unwanted or unused pharmaceuticals fact sheet
• Disposal practices for unused medications in New Zealand
• Disposal Practices for Unwanted Residential Medications in the United States
• Disposal vs Responsible Destruction of Pharmaceutical Waste
• Disposing of Expired Drugs and Chemicals: New Options for Compounders
• Disposing of Expired Drugs: a Matter of Policy
• Disruption of sexual selection in sand gobies (Pomatoschistus minutus) by 17α-ethinyl estradiol, an endocrine disruptor
• Disruption of zebrafish (Danio rerio) embryonic development after full life-cycle parental exposure to low levels of ethinylestradiol
• Dissipation of oxytetracycline in soils under different redox conditions
• Dissolved organic carbon from sewage sludge and manure can affect estrogen sorption and mineralization in soils
• Distribution and elimination of polycyclic musks in three sewage treatment plants of Beijing, China
• Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada
• DITOP: Drug-induced toxicity related protein database
• Diurnal variations in the occurrence and the fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway
• DNA Addresses Pharmaceutical Waste in the Water Supply
• DNA damaging potential of zinc oxide nanoparticles in human epidermal cells
• Do Biological Medicinal Products Pose a Risk to the Environment?: A Current View on Ecopharmacovigilance
• Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?
• Domestic Wastewater as a Source of Contaminants in Freshwater Aquifers in the Mayan Riviera Tourism Region of Mexico
• Don't Flush: What To Do With Your Unused Pharmaceuticals
• Don't Rush to Flush: Safer Pharmaceutical Practices for Hospice Home Care and Home Health Nurses
• Dopewater
• Dosed without prescription: Preventing pharmaceutical contamination of our nation’s drinking water
• Down the drain: medicines and other chemicals are creating new headaches
• Down the Drain: Pharmaceutical Waste Disposal in the United States
• Draft Directive on the local destruction of narcotics, controlled drugs and restricted drugs
• Draft European Parliament Legislative Resolution: proposal for a directive of the European Parliament and of the Council amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use (COM(2008)0665 - C6 0514/2008 - 2008/0260(COD))
• Drams of drugs and dregs - Excited chemicals pollute US streams
• Drinking Water Contaminants of Emerging Concern Program A Minnesota Clean Water Fund Initiative 2010-2011 Biennium, Interim Report
• Drinking water contamination mapped Wide-ranging survey reveals low levels of some drugs and pesticides in US tap water
• Drinking Water Quality: Problems and Solutions
• Drinking Water Strategy: A New Approach to Protecting Drinking Water and Public Health
• Drinking Water Strategy: A New Framework for Addressing Contaminants as Group(s) - WebDialogue Summary
• Drug Abuse Warning Network
• Drug Collection Events Aim to Keep Unused Prescriptions out of Wrong Hands
• Drug Companies Oppose Medicine 'take-back' Proposal
• Drug Database
• Drug Denaturing kits: DenKit - CD Destruction Kits
• Drug disposal
• Drug Disposal and Environmental Stewardship, invited presentation for teleconference call on Drug Disposal for area agencies on aging in Maryland
• Drug Disposal Bill Cleared for President
• Drug disposal guidelines approved, antimicrobial use task force to be formed
• Drug Disposal: Current Recommendations and Environmental Concerns
• Drug donations and Raising Awareness - Monitor the Guidelines on drug donations!
• Drug firms' cash skews doctor classes: Company-funded UW courses often favor medicine, leave out side effects
• Drug Free Water Act of 2008
• Drug Free Water Act of 2009
• Drug Free Water Act of 2009, H.R. 276, 111st Session of Congress
• Drug interactions with potential rubber closure extractables: Identification of thiol-disulfide exchange reaction products of captopril and thiurams
• Drug Interactions: CYTOCHROME P450 DRUG INTERACTION TABLE
• Drug making's move abroad stirs concerns
• Drug Manufacturers Directory
• Drug Pollution
• Drug pollution: Now the fish are taking Prozac
• Drug Recycling - Utilization of Unused Prescription Drugs Act (OS 59-367)
• Drug residuals: How xenobiotics can affect water supply sources
• Drug residues in waters: Role of human and veterinary activities
• Drug take-back plan killed in Maine
• Drug Takeback Programs National Day Planned
• Drug Take-Back Programs: What Will They Solve? Policymakers advocate regulation despite absence of science
• Drug wastage — what is acceptable?
• Drug Waste and Disposal: When Prescriptions Become Poison
• Drugged drinking water
• Drugged money
• Drugged waters - Does it matter that pharmaceuticals are turning up in water supplies
• Drugging the Waters: How an Aging Population and Growing Addiction to Pharmaceuticals May be Poisoning Our Rivers
• DrugMon: A biomarker–based tool to monitor community drug use and abuse in Norway: Monitoring of substances of abuse in wastewater effluents
• Drugs and Chemicals Straight From the Tap
• Drugs and Hormones as Pollutants of the Aquatic Environment: Determination and Ecotoxicological Impacts
• Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea
• Drugs and the Environment: Stewardship & Sustainability
• Drugs degrading photocatalytically: kinetics and mechanisms of ofloxacin and atenolol removal on titania suspensions
• Drugs down the drain
• Drugs found in tap water
• Drugs in municipal sewage effluents: screening and biodegradation studies
• Drugs in our drinking water: What do we do with unused medicines?
• Drugs in our drinking water: What do we do with unused medicines?
• Drugs in our water
• Drugs in the drinking water
• Drugs in the environment
• Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review
• Drugs in the evironment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources
• Drugs in the water
• Drugs in Wastewater: A Call for More Research, More Responsibility
• Drugs in your drinking water? No one knows
• Drugs of abuse and their metabolites in the Ebro River basin: Occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation
• Drugs on tap as the nights draw in
• Duke Poison Control Center: A Retrospective Exhibit. Official Creation of the Poison Control Center and the Growth of the National Poison Control Movement
• Dumping drugs puts traces of meds in taps
• Dynamic Exposure of Organisms and Passive Samplers to Hydrophobic Chemicals
• Dynamic Planar Solid Phase Microextraction Ion Mobility Spectrometry for Rapid Field Air Sampling and Analysis of Illicit Drugs and Explosives
• Eco-labelling of shampoos, shower gels and foam baths
• Ecological health assessments based on whole effluent toxicity tests and the index of biological integrity in temperate streams influenced by wastewater treatment plant effluents
• Ecological impact of antibiotic use in animals on different complex microflora: environment
• Economic Consequences of Unused Medications in Houston, Texas
• Ecopharmacology and its future forensic implications – An emerging science
• Ecopharmacology: A New Topic of Importance in Pharmacovigilance
• Ecopharmacology: Deliberated or casual dispersion of pharmaceutical principles, phytosanitary, personal health care and veterinary products in environment needs a multivariate analysis or expert systems for the control, the measure and the remediation,
• Ecopharmacostewardship - a pharmaceutical industry perspective
• Ecopharmacovigilance for Better Health
• Ecosystem response to antibiotics entering the aquatic environment
• Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals
• Ecotoxicity assessment of lipid regulators in water and biologically treated wastewater using three aquatic organisms
• Ecotoxicity tests in the environmental analysis of wastewater treatment plants: Case study in Portugal
• Ecotoxicogenomics: Emerging Technologies for Emerging Contaminants
• Ecotoxicological Aspects related to the presence of Pharmaceuticals in the Aquatic Environment
• Ecotoxicological effects of paracetamol on seed germination and seedling development of wheat (Triticum aestivum L.)
• Ecotoxicological effects of typical personal care products on seed germination and seedling development of wheat (Triticum aestivum L.)
• Ecotoxicological evaluation of the antimalarial drug chloroquine
• Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac
• Ecotoxicological multilevel-evaluation of the effects of fenbendazole exposure to Chironomus riparius larvae
• Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network
• Editorial to special issue in Water Research: Emerging contaminants in water
• e-Drug
• Education: Gateway to reuse acceptance begins with us
• Educational campaign for proper medication disposal
• Effect of 17b-estradiol on the immunocompetence of Japanese sea bass (lateolabrax japonicus)
• Effect of 17ß-estradiol on the immunocompetence of Japanese sea bass (lateolabrax japonicus)
• Effect of Antimicrobial Compounds Tylosin and Chlortetracycline during Batch Anaerobic Swine Manure Digestion
• Effect of Chlorination on the Estrogenic/Antiestrogenic Activities of Biologically Treated Wastewater
• Effect of cytostatic drug presence on extracellular polymeric substances formation in municipal wastewater treated by membrane bioreactor
• Effect of cytostatic drugs on microbial behaviour in membrane bioreactor system
• Effect of cytostatic drugs on the sludge and on the mixed liquor characteristics of a cross-flow membrane bioreactor; consequence on the process
• Effect of hypersaline aniline-containing pharmaceutical wastewater on the structure of activated sludge-derived bacterial community
• Effect of laundry activities on in-stream concentrations of linear alkylbenzene sulfonate in a small rural South African river
• Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor
• Effect of organic carbon and pH on soil sorption of sulfamethazine
• Effect of ozone exposure on the oxidation of trace organic contaminants in wastewater
• Effect of sample filtration on the quality of monitoring data reported for organic compounds during wastewater treatment
• Effect of triclosan and triclocarban biocides on biodegradation of estrogens in soils
• Effect of triclosan on microbial activity in Australian soils
• Effect Of Water-Matrix Composition On Trimethoprim Solar Photodegradation Kinetics And Pathways
• Effective approaches to minimize the problem of pharmaceuticals and other personal care products in the environment
• Effective controls of micropollutants included in wastewater effluent using constructed wetlands under anoxic condition
• Effectiveness Of Different Oxidizing Agents For Removing Sodium Dodecylbenzenesulphonate In Aqueous Systems
• Effects and Interactions in an Environmentally Relevant Mixture of Pharmaceuticals
• Effects of 17?-ethynylestradiol on early-life development, sex differentiation and vitellogenin induction in mummichog (Fundulus heteroclitus)
• Effects of 17beta-trenbolone in male eelpout Zoarces viviparus exposed to ethinylestradiol
• Effects of a Realistic Mixture of Antibiotics on Resistant and Nonresistant Sewage Sludge Bacteria in Laboratory-Scale Treatment Plants
• Effects of agricultural conditions on the leaching behaviour of veterinary antibiotics in soils
• Effects of binary mixtures of estrogen and antiestrogens on Japanese medaka (Oryzias latipes)
• Effects of chloramphenicol, florfenicol, and thiamphenicol on growth of algae Chlorella pyrenoidosa, Isochrysis galbana, and Tetraselmis chui
• Effects of chlorination on the persistence of pharmaceuticals in the environment
• Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis
• Effects of Ethinylestradiol on Medaka ( Oryzias latipes ) as Measured by Sperm Motility and Fertilization Success
• Effects of floc aluminum on activated sludge characteristics and removal of 17-[alpha]-ethinylestradiol in wastewater systems
• Effects of Fluoxetine Exposure on Serotonin-related Activity in the Sheepshead Minnow (Cyprinodon variegatus) using LC/MS/MS Detection and Quantitation
• Effects of fluoxetine on the reproduction of two prosobranch mollusks: Potamopyrgus antipodarum and Valvata piscinalis
• Effects of human pharmaceuticals on aquatic life: Next steps
• Effects of ibuprofen on the viability and proliferation of rainbow trout liver cell lines and potential problems and interactions in effects assessment
• Effects of ivermectin-spiked cattle dung on a water-sediment system with the aquatic invertebrates Daphnia magna and Chironomus riparius
• Effects of levofloxacin hydrochlordie on photosystem II activity and heterogeneity of Synechocystis sp
• Effects of lipid-lowering pharmaceuticals bezafibrate and clofibric acid on lipid metabolism in fathead minnow (Pimephales promelas)
• Effects of membrane degradation on the removal of pharmaceutically active compounds (PhACs) by NF/RO filtration processes
• Effects of o,p'-DDE, heptachlor, and 17?-estradiol on vitellogenin gene expression and the growth hormone/insulin-like growth factor-I axis in the tilapia, Oreochromis mossambicus
• Effects of ozone pre-treatment on diclofenac: Intermediates, biodegradability and toxicity assessment
• Effects of p,p' -DDE exposure on gonadal development and gene expression in Japanese medaka (Oryzias latipes)
• Effects of pharmaceutical mixtures in aquatic microcosms
• Effects of Pharmaceutical Wastes on Microbial Populations in Surface Waters at the Puerto Rico Dump Site in the Atlantic Ocean
• Effects of Pharmaceuticals on Aquatic Invertebrates. Part II: The Antidepressant Drug Fluoxetine
• Effects of Pollution on Freshwater Organisms
• Effects of ranitidine and its photoderivatives in the aquatic environment
• Effects of selected pharmaceuticals on arbuscular mycorrhizal fungi
• Effects of six selected antibiotics on plant growth and soil microbial and enzymatic activities
• Effects of sulfamethoxazole on soil microbial communities after adding substrate
• Effects of surface functional groups of activated carbon on adsorption of triclosan from aqueous solution
• Effects of synthetic gestagens on fish reproduction
• Effects of the antibiotic ciprofloxacin on the bacterial community structure and degradation of pyrene in marine sediment
• Effects of the polycyclic musk HHCB on individual- and population-level endpoints in Potamopyrgus antipodarum
• Effects of the synthetic estrogen, 17α-ethinylestradiol, on aggression and courtship behavior in male zebrafish (Danio rerio)
• Effects of the synthetic estrogen, 17a-ethinylestradiol, on aggression and courtship behavior in male zebrafish (Danio rerio)
• Effects of the UV filter benzophenone-2 on reproduction in fish
• Effects of the Veterinary Pharmaceutical Ivermectin on Soil Invertebrates in Laboratory Tests
• Effects of thiophanate-methyl and glyphosate on asexual and sexual reproduction in the rotifer Brachionus calyciflorus Pallas
• Effects of Three Pharmaceutical and Personal Care Products on Natural Freshwater Algal Assemblages
• Effects of treated municipal wastewater on the essential nutrient interactions in the plant of Brassica oleracea var. Italica
• Effects of triclosan on seed germination and seedling development of three wetland plants: sesbania herbacea, eclipta prostrata, and bidens frondosa
• Effects of wastewater and combined sewer overflows on water quality in the Blue River basin, Kansas City, Missouri and Kansas, July 1998 -October 2000
• Effects on feeding rate and biomarker responses of marine mussels experimentally exposed to propranolol and acetaminophen
• Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds
• Efficiency of nanofiltration for the elimination of steroids from water
• Efficient decomposition of pharmaceuticals through ozonisation
• Effluent from Bulk Drug Production is Toxic to Aquatic Vertebrates
• Effluent from drug manufactures contains extremely high levels of pharmaceuticals
• Effluent management in hospitals
• Efflux-Mediated Drug Resistance in Bacteria: An Update
• Electrochemical degradation of [beta]-blockers. Studies on single and multicomponent synthetic aqueous solutions
• Electrochemical degradation of Ibuprofen on Ti/Pt/PbO2 and Si/BDD electrodes
• Electrochemical Sensor for Rapid Detection of Triclosan Using a Multiwall Carbon Nanotube Film
• Electro-Fenton Process and Related Electrochemical Technologies Based on Fenton's Reaction Chemistry
• Electro-Fenton, UVA photoelectro-Fenton and solar photoelectro-Fenton degradation of the drug ibuprofen in acid aqueous medium using platinum and boron-doped diamond anodes
• Electro-Oxidation Of Reverse Osmosis Concentrates Generated In Tertiary Water Treatment
• Elimination of Organic Micropollutants in a Municipal Wastewater Treatment Plant Upgraded with a Full-Scale Post-Ozonation Followed by Sand Filtration
• Elimination of Pharmaceuticals and Personal Care Products in Subsurface Flow Constructed Wetlands
• Elimination of pharmaceuticals from wastewater by submerged nanofiltration plate modules
• Elimination of pharmaceuticals in sewage treatment plants in Finland
• email RE: National take-back program - what kind of incinerators?
• Emerging bacterial resistance following biocide exposure: should we be concerned?
• Emerging chemicals as pollutants in the environment: a 21st century perspective
• Emerging chemicals of concern: Pharmaceuticals and personal care products (PPCPs) in Asia, with particular reference to Southern China
• Emerging contaminants and the ramifications for environmental science
• Emerging contaminants in drinking water: What to do?
• Emerging contaminants in wastewaters
• Emerging Contaminants of Environmental Concern: Source, Transport, Fate, and Treatment
• Emerging Contaminants Targeted in a Reconnaissance of Ground Water and Untreated Drinking-Water Sources
• Emerging contaminants: antibiotics in aquatic and terrestrial ecosystems
• Emerging Contaminants: Insights to the Most Effective EDC and PPCP Treatment Strategies
• Emerging contaminants--pesticides, PPCPs, microbial degradation products and natural substances as inhibitors of multixenobiotic defense in aquatic organisms
• Emerging Liabilities from Pharmaceuticals and Personal Care Products
• Emerging Pollutants
• Emerging Pollutants
• Emerging Pollutants
• Emerging Pollutants
• Emerging Pollutants - Questions, Challenges, and the Future
• Emerging pollutants, and communicating the science of environmental chemistry and mass spectrometry: pharmaceuticals in the environment
• Emerging Water Contaminants: Technical, Legal and Policy Challenges
• Emission of biocides from hospitals: Comparing current survey results with European Union default values
• Emissions investigation for a novel medical waste incinerator
• Empirical Model for Predicting Concentrations of Refractory Hydrophobic Organic Compounds in Digested Sludge from Municipal Wastewater Treatment Plants
• Empowering clinics with technology and community
• Emptying our medicine cabinets into our waters
• Enantioselective chromatography--A powerful tool for the discrimination of biotic and abiotic transformation processes of chiral environmental pollutants
• enate passes prescription drug disposal bill (S. 3397)
• Endocrine - Disrupting Chemical Pollution: Why the EPA Should Regulate These Chemicals Under the Clean Water Act
• Endocrine and Reproductive Effects of the Pharmaceutical Fluoxetine on Native Freshwater Mussels: Proximity to Measured Environmental Concentrations
• Endocrine Disrupting Chemicals (EDCs) and Pharmaceuticals and Personal Care Products (PPCPs) in Reclaimed Water in Australia
• Endocrine disrupting chemicals in drinking water: Risks to human health and the environment
• Endocrine disrupting chemicals in fish: Developing exposure indicators and predictive models of effects based on mechanism of action
• Endocrine disrupting chemicals in indoor and outdoor air
• Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health
• Endocrine disrupting compounds and other emerging contaminants in the environment: A survey on new monitoring strategies and occurrence data
• Endocrine disrupting compounds removal from wastewater, a new challenge
• Endocrine Disrupting Compounds: A Report to the Minnesota Legislature
• Endocrine disruption and consequences of chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes) and freshwater cladocerans Daphnia magna and Moina macrocopa
• Endocrine Disruption in Aquatic Vertebrates
• Endocrine disruption in wild populations of chub (Leuciscus cephalus) in contaminated French streams
• ENDOCRINE DISRUPTOR SCREENING PROGRAM
• Endocrine Disruptor Screening Program (EDSP)
• Endocrine disruptors and pharamaceuticals in drinking water
• Endocrine disruptors and the water industry - The endocrine disruptor issue is one of a series of environmental and health concerns that the water industry must prepare for.
• Endocrine disruptors in bottled mineral water: total estrogenic burden and migration from plastic bottles
• Endocrine Disruptors in Drinking Water
• Endocrine disruptors in sewage treatment plants, receiving waters and sediments. Integration of chemical analysis and effect studies on carps and yeast
• Endocrine disruptors, pharmaceuticals, and personal care products CD-ROM
• Endocrine Disruptors, Pharmaceuticals, and Personal Care Products in Drinking Water: An Overview of AwwaRF Research to Date
• Endocrine effects of polycyclic musks: do we smell a rat?
• Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
• Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
• Endocrine-Disrupting Compounds in Wastewater, Sludge-Treatment Processes, and Receiving Waters: Overview
• Endocrine-disrupting compounds: A review of their challenge to sustainable and safe water supply and water reuse
• Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
• Enhanced Analysis of Steroids by Gas Chromatography/Mass Spectrometry using Microwave-Accelerated Derivatization
• Enhanced mechanism of catalytic ozonation by ultrasound with orthogonal dual frequencies for the degradation of nitrobenzene in aqueous solution
• Enhanced transformation of triclosan by laccase in the presence of redox mediators
• Enhancement of organic removals in high strength herbal pharmaceutical wastewater
• Enviromental Impact and Risk of CAFOs
• Environmental Analysis of Selected Estrogens and Androgens: Applying Ultra-Performance Liquid Chromatography and Combating Matrix Interference
• Environmental and human health risk assessment of organic micro-pollutants occurring in a Spanish marine fish farm
• Environmental and Regulatory Aspects
• Environmental Aspects of the Disposal of Pharmaceuticals in New Zealand
• Environmental assessment of anaerobically digested sludge reuse in agriculture: Potential impacts of emerging micropollutants
• Environmental assessment of human pharmaceuticals in the United States of America
• Environmental Control of Biotechnology Industry
• Environmental effects of human pharmaceuticals
• Environmental effects of pharmaceuticals, cosmetics and hygiene products
• Environmental exposure modeling and monitoring of human pharmaceutical concentrations in the environment, in Human pharmaceuticals: assessing the impacts on aquatic ecosystems
• Environmental Exposure of Aquatic and Terrestrial Biota to Triclosan and Triclocarban
• Environmental Exposure of Aquatic and Terrestrial Biota to Triclosan and Triclocarban
• Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania
• Environmental fate and transport of human pharmaceuticals
• Environmental Fate of Pharmaceuticals in Water/Sediment Systems
• Environmental fate of the anthelmintic ivermectin in an aerobic sediment/water system
• Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems
• Environmental fate processes and biochemical transformations of chiral emerging organic pollutants
• Environmental Footprint of Pharmaceuticals - The Significance of Factors Beyond Direct Excretion to Sewers
• Environmental Hazard Assessment of Pharmaceuticals
• Environmental Health Impacts of Equine Estrogens Derived from Hormone Replacement Therapy
• Environmental Health: Action Needed to Sustain Agencies’ Collaboration on Pharmaceuticals in Drinking Water
• Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies
• Environmental mass spectrometry: Emerging contaminants and current issues
• Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater mussels
• Environmental pollution by antibiotics and by antibiotic resistance determinants
• Environmental pollution in Latin America: The case of Puerto Rico - Pharmaceuticals and the water crisis
• Environmental Presence and Persistence of Pharmaceuticals: An Overview
• Environmental Regulation Update for the Healthcare Professional
• Environmental Research Brief: Pollution prevention assessment for a manufacturer of pharmaceuticals
• Environmental Return System. Convenient and confidential usused patient medical disposal solutions
• Environmental risk and toxicology of human and veterinary waste pharmaceutical exposure to wild aquatic host-parasite relationships
• Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001
• Environmental Risk Assessment for the Galenical Formulation of Solid Medicinal Products at Roche Basle, Switzerland
• Environmental Risk Assessment for the Widely Used Iodinated X-Ray Contrast Agent Iopromide (Ultravist)
• Environmental risk assessment of antibiotics: An intensive care unit analysis
• Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol
• Environmental risk assessment of pharmaceutical drug substances--conceptual considerations
• Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments
• Environmental Risk Assessment of Pharmaceuticals
• Environmental risk assessment of pharmaceuticals in rivers: Relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain)
• Environmental risk assessment of pharmaceuticals in the EU - A regulatory perspective
• Environmental risk assessment of pharmaceuticals: a proposal with special emphasis on european aspects
• Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
• Environmental risk assessment of veterinary medicinal products in the EU--a regulatory perspective
• Environmental risks of musk fragrance ingredients, in Pharmaceuticals and personal care products in the environment: scientific and regulatory
• Environmental safety aspects of personal care products - A European perspective
• Environmental sources, occurrence, and effects of synthetic musk fragrances
• Environmental Stewardship of Pharmaceuticals: The Green Pharmacy
• Environmentally Classified Pharmaceuticals
• Environmentally Classified Pharmaceuticals - database
• ENVIROPHARM 2010
• EnviroRx e-Newsletter
• ENVIRx Pharmaceutical Stewardship Programme
• Enzymatic degradation of tetracycline and oxytetracycline by crude manganese peroxidase prepared from Phanerochaete chrysosporium
• Enzymatic treatment of estrogens and estrogen glucuronide
• Enzymes of carbohydrate metabolism as potential drug targets
• EPA Collecting Information on Disposal of Unused Medications
• EPA expected to finalize new pharmaceutical waste rule in 2010
• EPA Eyes Unused Pharmaceuticals
• EPA May Prohibit Cruise Ship Sewage 3 Miles from Shore
• EPA Names Six Chemicals, Chemical Groups for Which it Plans to Release Action Plans
• EPA pharmaceutical survey not for veterinarians, AVMA says
• EPA pilot study of pharmaceuticals in fish tissue
• EPA scales back waste disposal survey
• EPA Seeks Public Comment on Petition From Advocacy Groups to Regulate Triclosan
• EPA, Public Interest Advocates Settle RRP Lawsuit—Additional Protections Required
• EPA/Office of Water's Strategy for Contaminants of Emerging Concern (presentation)
• EPA-Household waste drop-off
• EPA's New Chemicals Program: TSCA dealt EPA a very poor hand
• Epinephrine Salts – Medicinal Nitroglycerine – P & U Listed Syringe Waste
• Erratum to "Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1" [Aquat. Toxicol. 90 (2008) 214-222]
• Erratum to "Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field" [Science of the Total Environment 407 (2009) 4596-4604]
• Erratum to "The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters" [Water Research 43 (2009) 2]
• Erratum to Cocaine and metabolites in waste and surface water across Belgium
• Erratum to Removal of pharmaceuticals and fragrances in biological wastewater treatment
• Erratum: Pharmaceuticals and personal care products in the environment: agents of subtle change?
• Essential Services: Waste Management
• Estimating Chronic Exposure to Steroid Hormones in Water
• Estimating Community Drug Abuse by Wastewater Analysis
• Estimating the sorption of pharmaceuticals based on their pharmacological distribution
• Estimation of the cancer, risk to humans from cyclophoshamide and ifosfamide excreta emitted into surface water via hospital effluents
• Estrogen Biodegradation Kinetics and Estrogenic Activity Reduction for Two Biological Wastewater Treatment Methods
• Estrogen concentration affects its biodegradation rate in activated sludge
• Estrogen in a karstic aquifer
• Estrogen removal from treated municipal effluent in small-scale constructed wetland with different depth
• Estrogenic activity of pharmaceuticals in the aquatic environment
• Estrogenic activity of ternary UV filter mixtures in fish (Pimephales promelas) - An analysis with nonlinear isobolograms
• Estrogenic activity of US drinking waters: A relative exposure comparison
• Estrogenic and androgenic effects of municipal wastewater effluent on reproductive endpoint biomarkers in three-spined stickleback (gasterosteus aculeatus)
• Estrogenic and dioxin-like activities and cytotoxicity of sediments and biota from Hong Kong mudflats
• Estrogenic chemicals and estrogenicity in river waters of South Korea and seven Asian countries
• Estrogenic Compounds Downstream From Three Small Cities in Eastern Nebraska: Occurrence and Biological Effect
• Estrogenic compounds in seawater and sediment from Halifax harbour, Nova Scotia, Canada
• Estrogenic Profile of the Svratka and Svitava Rivers in the Brno Area
• Estrogenic Wastewater Treatment Works Effluents Reduce Egg Production in Fish
• Estrogenic Compounds Downstream from Three Small Cities in Eastern Nebraska: Occurrence and Biological Effect
• Estrogenic, anti-estrogenic and cytotoxic effects elicited by water from the type localities of the endangered goodeid fish Girardinichthys viviparus
• Estrogenicity and Nutrient Concentration of Surface Waters Surrounding a Large Confinement Dairy Operation Using Best Management Practices for Land Application of Animal Wastes
• Estrogens and their conjugates: Determination in water samples by solid-phase extraction and liquid chromatography-tandem mass spectrometry
• Estrogens disrupt serotonin receptor and cyclooxygenase mRNA expression in the gonads of mussels (Mytilus edulis)
• Estrogens from sewage in coastal marine environments
• EU Water Framework Directive and Stockholm Convention
• EU-Project Poseidon: Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse
• Europe Finds Clean Energy in Trash, but U.S. Lags
• Europe leads effort to push for design of "green" drugs
• European regulations
• European Technology Platform NANOMEDICINE
• EU-wide survey of polar organic persistent pollutants in European river waters
• Evaluating simple and complex mixtures containing pharamaceuticals in the environment
• Evaluating the environmental fate of pharmaceuticals using a level III model based on poly-parameter linear free energy relationships
• Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges
• Evaluation of a carp primary hepatocyte culture system for screening chemicals for oestrogenic activity
• Evaluation of a Photocatalytic Reactor Membrane Pilot System for the Removal of Pharmaceuticals and Endocrine Disrupting Compounds from Water
• Evaluation of advanced treatment technologies for the elimination of pharmaceutical compounds
• Evaluation of an hPXR reporter gene assay for the detection of aquatic emerging pollutants: screening of chemicals and application to water samples
• Evaluation of Drug Waste Minimization and Drug Disposal (in Korean)
• Evaluation of emerging contaminants of concern at the South District Wastewater Treatment Plant based on seasonal sampling events, Miami-Dade County, Florida, 2004,
• Evaluation of endocrine disrupting effects in Potomac River fish
• Evaluation of estrogenic activity from a municipal wastewater treatment plant with predominantly domestic input
• Evaluation of estrogenic activity of parabens and their chlorinated derivatives by using the yeast two-hybrid assay and the enzyme-linked immunosorbent assay
• Evaluation of estrogenic disrupting potency in aquatic environments and urban wastewaters by combining chemical and biological analysis
• Evaluation of Home-Generated Pharmaceutical Programs in California: CalRecycle Background Paper for July 20, 2010 Workshop
• Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products
• Evaluation of Pharmaceuticals and Personal Care Products as Water-soluble Molecular Markers of Sewage
• Evaluation of principal cannabinoids in airborne particulates
• Evaluation of QSPR Techniques for Wastewater Treatment Processes
• Evaluation of teratogenic effects produced by water samples from wastewater and drinking water treatment plants by zebrafish embryo test
• Evaluation of the accuracy and consistency of the Swedish Environmental Classification and Information System for pharmaceuticals
• Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata
• Evaluation of the OECD 314B Activated Sludge Die-Away Test for Assessing the Biodegradation of Pharmaceuticals
• Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas)
• Evaluation of UV/H2O2 treatment for the oxidation of pharmaceuticals in wastewater
• Evaluation of various liquid chromatography-quadrupole-linear ion trap-mass spectrometry operation modes applied to the analysis of organic pollutants in wastewaters
• Even If You're Careful, Drugs Can End up in Water
• Evidence for inhibition of cholinesterases in insect and mammalian nervous systems by the insect repellent deet
• Evidence of Increasing Antibiotic Resistance Gene Abundances in Archived Soils since 1940
• Evidencing Generation of Persistent Ozonation Products of Antibiotics Roxithromycin and Trimethoprim
• Evolution of antibiotic occurrence in a river through pristine, urban and agricultural landscapes
• Evolution of ecotoxicity upon Fenton's oxidation of phenol in water,
• EWG Research: Bottled Water Quality Investigation: 10 Major Brands, 38 Pollutants
• EWG Research: Bottled Water Quality Investigation: 10 Major Brands, 38 Pollutants. Bottled water contains disinfection byproducts, fertilizer residue, and pain medication
• Examining Unused Pharmaceuticals in the Environment
• Excreted drugs: Something looks fishy
• Excreted tamiflu found in rivers
• Excretion and ecotoxicity of pharmaceutical and personal care products in the environment
• Executive Summary: Reducing Prescription Drug Misuse Through the Use of a Citizen Mail-Back Program in Maine
• Executive Summary: Reducing Prescription Drug Misuse Through the Use of a Citizen Mail-Back Program in Maine
• Experiences from a biomarker study on farmed rainbow trout (oncorhynchus mykiss) used for environmental monitoring in a swedish river
• Experiences with the Swedish environment classification scheme
• Experiences with the Swedish environmental classification system of pharmaceuticals on www.fass.se
• Experimental study of behavior of endocrine-disrupting chemicals in leachate treatment process and evaluation of removal efficiency
• Expert Stakeholders’ Views on the Management of Human Pharmaceuticals in the Environment
• Expert: Medicines pollute world waters
• Expired medication boxes ready for use
• Exposure Assessment of 17alpha-Ethinyl Estradiol in Surface Waters of the United States and Europe
• Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input
• Exposure to 17?-ethynylestradiol impairs reproductive functions of both male and female zebrafish (Danio rerio)
• Exposure to pharmaceuticals present in the environment
• Exposure to Treated Sewage Effluent Disrupts Reproduction and Development in the Seasonally Breeding Ramshorn Snail (Subclass: Pulmonata, Planorbarius corneus)
• Expression Signatures for a Model Androgen and Antiandrogen in the Fathead Minnow (Pimephales promelas) Ovary
• Extending the environmental risk assessment for oseltamivir (Tamiflu®) under pandemic use conditions to the coastal marine compartment
• Extraction and detection of pharmaceuticals and personal care products in north Alabama water using gas chromatograph-mass spectrometry analysis
• Extraction and mechanism investigation of trace roxithromycin in real water samples by use of ionic liquid-salt aqueous two-phase system
• Extractive Electrospray Ionization Mass Spectrometry toward in Situ Analysis without Sample Pretreatment
• Factories dumping drugs into sewage: Samples taken contained opiates, a barbiturate and a tranquilizer
• Factors Affecting the Concentrations of Pharmaceuticals Released to the Aquatic Environment
• Factors affecting the degradation of pharmaceuticals in agricultural soils
• Factors driving the development of healthcare waste management in the United Kingdom over the past 60 years
• Factors impacting on pharmaceutical leaching following sewage application to land
• Fake Pharmaceuticals: Those fighting against counterfeit medicines face increasingly sophisticated adversaries
• FAQs About Proper Disposal of Drugs
• Fast and Selective Extraction of Sulfonamides from Honey Based on Magnetic Molecularly Imprinted Polymer
• Fast Liquid Chromatography-Quadrupole-Linear Ion Trap Mass Spectrometry for the Analysis of Pharmaceuticals and Hormones in Water Resources
• Fast screening immunoassay of sulfonamides in commercial fish samples
• Fatal drug poisonings in a Swedish general population
• Fatal embryo chondral damage associated with fluoroquinolones in eggs of threatened avian scavengers
• Fate and analysis of pharmaceutical residues in the aquatic environment
• Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment
• Fate and Effects of Fluoroquinolone Antibacterial Agents in Aquatic Ecosystems
• Fate and Effects of Little Investigated Scents in the Aquatic Environment
• Fate and effects of octylphenol in a Microcystis aeruginosa culture medium
• Fate and effects of sediment-associated acetyl cedrene in sediments inhabited by the deposit feeder, Capitella sp. I
• Fate and occurrence of pharmaceuticals in the water cycle – Ecotoxicity of pharmaceuticals
• Fate and occurrence of pharmaceuticals in the water cycle – Occurrence of pharmaceuticals in the acqueous environment
• Fate and occurrence of pharmaceuticals in the water cycle – Transformation of pharmaceuticals in the environment: Photolysis and other abiotic processes
• Fate and removal of estrogens in municipal wastewater
• Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration
• Fate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste
• Fate and transport of pharmaceutical and personal care products in the Detroit River
• Fate and transport of pharmaceuticals and endocrine disrupting compounds during ground water recharge
• Fate and Transport of Sulfadimethoxine and Ormetoprim in Two Southeastern United States Soils
• Fate and Transport Modeling of Potential Pathogens: The Contribution from Sediments
• Fate of β-blocker human pharmaceuticals in surface water: Comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland
• Fate of Amoxicillin in Mixed-Culture Bioreactors and Its Effects on Microbial Growth and Resistance to Silver Ions
• Fate of antibacterial spiramycin in river waters
• Fate of artificial musk fragrances associated with suspended particulate matter (SPM) from the River Elbe (Germany) in comparison to other organic contaminants
• Fate of beta blockers and psycho-active drugs in conventional wastewater treatment
• Fate of Beta Blockers in Aquatic-Sediment Systems: Sorption and Biotransformation
• Fate of Carbamazepine during Water Treatment
• Fate of Conjugated Natural and Synthetic Steroid Estrogens in Crude Sewage and Activated Sludge Batch Studies
• Fate of Endocrine Disrupting Compounds in Membrane Bioreactor Systems
• Fate of Endocrine-Disruptor, Pharmaceutical, and Personal Care Product Chemicals during Simulated Drinking Water Treatment Processes
• Fate of estrogens and xenoestrogens in four sewage treatment plants with different technologies
• Fate of lincomycin in snowmelt runoff from manure-amended pasture
• Fate of Nine Recycled Water Trace Organic Contaminants and Metal(loid)s during Managed Aquifer Recharge into a Anaerobic Aquifer: Column Studies
• Fate of Organohalogens in U.S. Wastewater Treatment Plants and Estimated Chemical Releases to Soils Nationwide from Biosolids Recycling
• Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge
• Fate of Pharmaceutical Residues during Ground Water Recharge: Final Results from the Nasri Project (2002-2005)
• Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage
• Fate of pharmaceuticals and personal care products in wastewater treatment plants - Conception of a database and first results
• Fate of Pharmaceuticals and Personal Care Products through Wastewater Treatment Processes
• Fate of Pharmaceuticals During Ground Water Recharge
• Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation
• Fate of pharmaceuticals in the environment and in water treatment systems
• Fate of pharmaceuticals, personal care products and hormones in municipal wastewater treatment - a new challenge for wastewater management
• Fate of polybrominated diphenyl ethers, nonylphenol, and estrogenic activity during managed infiltration of wastewater effluent
• Fate of Silica Nanoparticles in Simulated Primary Wastewater Treatment
• Fate of Sulfamethoxazole, 4-Nonylphenol, and 17?-estradiol in Groundwater Contaminated by Wastewater Treatment Plant Effluent
• Fate of the Antibiotic Sulfamethoxazole and Its Two Major Human Metabolites in a Water Sediment Test
• Fate of the nonsteroidal anti-inflammatory drug naproxen in agricultural soil receiving liquid municipal biosolids
• Fate of trace organic compounds during vadose zone soil treatment in an onsite wastewater system
• Fate of Triclosan and Evidence for Reductive Dechlorination of Triclocarban in Estuarine Sediments
• FDA Issues Draft Guidance on the Judicious Use of Medically Important Antimicrobials in Food-Producing Animals
• FDA outlines new Rx labeling
• FDA says studies on triclosan, used in sanitizers and soaps, raise concerns
• FDA Warns About Fraudulent Tamiflu: Fraudulent product is dangerous to patients allergic to penicillin
• FDA: First Drug to Treat Cancer in Dogs Approved
• Feasibility of a Clinical Chemical Analysis Approach To Predict Misuse of Growth Promoting Hormones in Cattle
• Feasibility of nanofiltration for the removal of endocrine disrupting compounds
• Fecal steroids in riverine runoff of the Pearl River Delta, South China: Levels, potential sources and inputs to the coastal ocean
• Federal Controlled Substance Laws and Regulations
• Feds Not Addressing Drugs in Water
• Fees delay pharmed drug: European trial of 'pharmed' anti-HIV monoclonal delayed by costly regulatory process
• Feminized Fish and Vulnerable Vultures - Pharmaceuticals as Environmental Pollutants Require Novel Testing Approaches
• Fenton-Biological Treatment Processes for the Removal of Some Pharmaceuticals from Industrial Wastewater
• Fight Grows Over Labels on Household Cleaners
• Fighting Antibiotic Resistance: Marrying New Financial Incentives to Meeting Public Health Goals
• Filter the options to clear chemicals from tap water
• Finding A Final Resting Place For Old Drugs
• Finding Solutions: Custom manufacturers take on drug solubility issues to help pharmaceutical firms move products through development
• First interlaboratory study on NSAID residue analysis in water
• Fish Drug/Chemical Analysis Phish-Pharm (FDA-PP) database
• Fish on morphine: protecting Wisconsin's natural resources through a comprehensive plan for proper disposal of pharmaceuticals
• Fish Pharm: Pharmaceutical Waste and the Environment
• Fish: Response to Ocean-Dumped Pharmaceutical Wastes
• Flow Injection Analysis-Solid Phase Extraction (FIA-SPE) Method for Preconcentration and Determination of Trace Amounts of Penicillins Using Methylene Blue Grafted Polyurethane Foam
• Fluoroquinolone antibiotic determination in bovine, ovine and caprine milk using solid-phase extraction and high-performance liquid chromatography-fluorescence detection with ionic liquids as mobile phase additives
• Fluoroquinolone antibiotics determination in piggeries environmental waters
• Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish brain
• Fluoxetine and Norfluoxetine Revisited: New Insights into the Electrochemical and Spectroscopic Properties
• Fluoxetine treatment affects nitrogen waste excretion and osmoregulation in a marine teleost fish
• Flushing drugs down toilet leads to medical license suspension
• Fluvial biofilms: A pertinent tool to assess β-blockers toxicity
• Flux enhancement of stagnant sandwich compared to supported liquid membrane systems in the removal of Gemfibrozil from waters
• Forecast of Pharmaceutical Consumption in the Netherlands Using Demographic Projections
• Forecasting risk along a river basin using a probabilistic and deterministic model for environmental risk assessment of effluents through ecotoxicological evaluation and GIS
• Forensic labs warn of deuterated drug threat
• Foreword: JEM Spotlight: Recent advances in analysis of pharmaceuticals in the aquatic environment
• Fotokatalityczna degradacja doksycykliny w roztworach wodnych [Photocatalytic degradation of doxycycline in water solutions]
• Fourth National Report on Human Exposure to Environmental Chemicals
• Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables
• Fragrance: emerging health and environmental concerns
• Fragranced consumer products and undisclosed ingredients
• Fragranced Products Information Network
• Frederick County takes on drugs in waste water
• Free drugs from your faucet
• Free-radical-induced oxidative and reductive degradation of N,N'-diethyl-m-toluamide (DEET): Kinetic studies and degradation pathway
• Freeze concentration for removal of pharmaceutically active compounds in water
• Frequently Asked Questions on Pharmaceutical and Personal Care Products (PPCPs)
• From dispensing to disposal: the role of student pharmacists in medication disposal and the implementation of a take-back program
• From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas
• From Smokestack to SUV: The Individual as Regulated Entity in the New Era of Environmental Law
• From Source Water to Drinking Water: Workshop Summary
• FSIS National Residue Program for Cattle
• Full - scale Experimental Research on 6 - APA Wastewater Treatment
• Fullerene to treat multiple sclerosis
• Fully Automatic Sample Treatment by Integration of Microextraction by Packed Sorbents into Commercial Capillary Electrophoresis - Mass Spectrometry Equipment: Application to the Determination of Fluoroquinolones in Urine
• Fundamental Changes Could Be in Store for Regulation of Commercial Chemicals
• Fusarium Mycotoxins: Overlooked Aquatic Micropollutants?
• Gamma Irradiation Of Pharmaceutical Compounds, Nitroimidazoles, As A New Alternative For Water Treatment
• GAO: No evidence-based need for third class of drugs
• Gas Chromatography/Surface-Assisted Laser Desorption Ionization Mass Spectrometry of Amphetamine-like Compounds
• Gas chromatography-mass spectrometry screening methods for select UV filters, synthetic musks, alkylphenols, an antimicrobial agent, and an insect repellent in fish
• Gas-liquid chromatography- tandem mass spectrometry methodology for the quantitation of estrogenic contaminants in bile of fish exposed to wastewater treatment works effluents and from wild populations
• Gauging the pharmaceutical burden on Sydney's environment: a preventative response
• GC-MS/MS measurement of natural and synthetic estrogens in receiving waters and mussels close to a raw sewage ocean outfall
• Gene expression profiling in the deep water horse mussel Modiolus modiolus (L.) located near a marine municipal wastewater outfall
• Gene expression responses in male fathead minnows exposed to binary mixtures of an estrogen and antiestrogen
• Generation of a Fluorescent Transgenic Zebrafish for Detection of Environmental Estrogens
• Genetic analysis of protoplast fusant Xhhh constructed for pharmaceutical wastewater treatment
• Genotoxic effects of wastewater from an oncological ward
• Genotoxic Impurities: From Structural Alerts to Qualification
• Genotoxicity assessment of a pharmaceutical effluent using four bioassays
• Genotoxicity evaluation of hospital wastewaters
• Geographic Variation in Medicare Drug Spending
• Gerenciamento e destinação final de medicamentos: uma iscussão sobre o problema [Management and medicines' disposal: a discussion about the problem]
• Germ killers - Could widely used biocide triclosan, found in common household products, pose a health risk?
• Get Rid of Unused Prescription Drugs Without Contaminating Your Drinking Water
• Getting Straight on What's Flushed Sewage Epidemiology Measures Community Drug Consumption
• Global Public Policy Issues: GlaxoSmithKline’s Position - Pharmaceuticals in the Environment
• Good medicine: A quick-start guide to managing pharmaceutical waste
• GoodGuide
• Green Pharmacy Growing Around the Nation
• Green pharmacy pilot program goes national
• Green Pharmacy Toolkit
• Green Prescriptions
• Greener pharmaceuticals
• Greywater pollution variability and loadings
• Groundwater contamination by microbiological and chemical substances released from hospital wastewater: Health risk assessment for drinking water consumers
• Groundwater quality impacts from the land application of treated municipal wastewater in a large karstic spring basin: Chemical and microbiological indicators
• Groundwater recharge and chemical contaminants: Challenges in communicating the connections and collisions of two disparate worlds
• Group faults water testing, treatment
• Groups to sue cleaning product makers for ingredient disclosure
• Growth and contaminant dynamics of Lake Superior lake trout
• Growth and development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and sertraline, throughout metamorphosis
• Growth-inhibiting effects of twelve antibacterial agents and their mixtures on the freshwater microalga pseudokirchneriella subcapitata
• Guidance Document: Best Management Practices for Unused Pharmaceuticals at Health Care Facilities (draft)
• Guidance for Industry: Incorporation of physical - chemical identifiers into solid oral dosage form drug products for anticounterfeiting
• Guidance for Industry: Residual Drug in Transdermal and Related Drug Delivery Systems
• Guidance for school nurses on disposal of student medications
• Guidance on changes in the management of Controlled Drugs
• Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies
• Guidelines on the environmental risk assessment of medicinal products for human use
• H.R. 1145: To implement a National Water Research and Development Initiative, and for other purposes
• H.R. 1191: Safe Drug Disposal Act of 2009
• H.R. 1262: Water Quality Investment Act of 2009
• H.R. 3590: Patient Protection and Affordable Care Act of 2010 (PPACA) [Public Law No: 111-148] Section 3310 - Reducing wasteful dispensing of outpatient prescription drugs in longterm care facilities under prescription drug plans and MA-PD plans
• H.R. 5809: Safe Drug Disposal Act of 2010. to amend the Controlled Substances Act to provide for take-back disposal of controlled substances in certain instances, and for other purposes
• H.R.1549/S.619: PAMTA - Preservation of Antibiotics for Medical Treatment Act of 2009
• H.R.5320: Assistance, Quality, and Affordability Act of 2010 ("AQUA") (Introduced in House)
• H2O2/UV-C treatment of the commercially important aryl sulfonates H-, K-, J-acid and Para base: Assessment of photodegradation kinetics and products
• Habitats and Ecosystems, Disposal of Unwanted Medicines: A Resource for Action in Your Community, unwanted meds/updated Toolkit Materials
• Handheld Miniature Ion Trap Mass Spectrometers
• Handling of unused prescription drugs -- knowledge, behaviour and attitude among Swedish people
• Hazardous organic compounds in urban municipal solid waste from a developing country
• he endocrine disrupting activity of surface waters and of wastewater treatment plant effluents in relation to chlorination
• he use of biochemical responses to assess ecotoxicological effects of Pharmaceutical and Personal Care Products (PPCPs) after injection in the mussel Elliptio complanata
• Health Care Waste Summit 2009
• Health Effects Associated with Wastewater Treatment, Reuse, and Disposal
• Health effects from reported exposure to methamphetamine labs: A poison center-based study
• Health experts look at new strategies to reduce drug waste, minimize environmental impact, and limit drug diversion
• Health facilities, NY settle over drug-flushing
• Healthcare facilities discharge hazardous pharmaceutical waste
• Healthcare waste management in Algeria and Mostaganem department
• Hearings on Tap Water Planned
• Heavy Drugs
• Heavy Hydrogen Promises Better Versions of Current Drugs
• Heavy Metal Exposure from Personal Care Products
• Heavy-Hydrogen Drugs Turn Heads, Again
• Heavyweight drugs: Swapping selected hydrogen atoms for deuterium could be a fast route to making safer, longer lasting drugs
• Heller School's prescription for excellence: new drug monitoring center
• Hepatic antioxidant status and hematological parameters in rainbow trout, Oncorhynchus mykiss, after chronic exposure to carbamazepine
• HERBAL DIETARY SUPPLEMENTS: Examples of Deceptive or Questionable Marketing Practices and Potentially Dangerous Advice
• Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals
• High Acceptance of Urine Source Separation in Seven European Countries: A Review
• High on pollution: Drugs as environmental contaminants
• High Performance Liquid Chromatography-Tandem Mass Spectrometry of Pharmaceuticals and Personal Care Products in Environmental and Biological Matrices
• Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action
• High-through put analysis of tetracycline antibiotics and their epimers in liquid hog manure using Ultra Performance Liquid Chromatography with UV detection
• Hindsight rather than foresight: reality versus the EU draft guideline on pharmaceuticals in the environment
• Historical Census of Housing Tables: Sewage Disposal
• Historical reconstruction of wastewater and land use impacts to groundwater used for public drinking water: Exposure assessment using chemical data and GIS
• History of wildlife toxicology
• Hollow Fiber Supported Ionic Liquid Membrane Microextraction for Determination of Sulfonamides in Environmental Water Samples by High-performance Liquid Chromatograph
• Hollow-fibre supported liquid membrane extraction for determination of fluoxetine and norfluoxetine concentration at ultra trace level in sewage samples
• Hormesis: A conversation with a critic
• Hormetic effect(s) of tetracyclines as environmental contaminant on Zea mays
• Hospice Nurses and Drug Disposal: The Convergence Between Nursing Practice and the Environment
• Hospital wastewater genotoxicity
• Hospital/Medical/Infectious Waste Incinerators
• Household disposal of pharmaceuticals and perception of risk to the environment
• Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom
• Household Hazardous Waste: Pharmaceutical Drug Waste
• Household Pharmaceutical Waste: Recommended Disposal Options for Households
• Household pharmaceutical waste: Regulatory and management issues
• How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?
• How do you select the “greenest” technology? Development of guidance for the pharmaceutical industry
• How drugs are polluting our water
• How physicians try to prevent 'doctor shopping'
• How the body's 'garbage disposal' may inactivate drugs
• How to address unused medicine disposal in New Hampshire
• How to avoid pharmaceuticals in the aquatic environment
• How to dispose of unused medicines
• How To Prevent Poisoning In Ferrets: Ferrets eat the strangest things, but owners can protect their pets from poisoning by being aware of possible dangers
• How to Use Water Quality Goals Online
• HP 557 LD 821: An Act To Support Collection and Proper Disposal of Unwanted Drugs
• HPLC and LC/MS Analysis of Pharmaceutical Container Closure System Leachables and Extractables
• HPLC determination of ibuprofen, diclofenac and salicylic acid using hollow fiber-based liquid phase microextraction (HF-LPME)
• HR 1359: Secure and Responsible Drug Disposal Act of 2009
• Human and Veterinary Pharmaceuticals, Narcotics, and Personal Care Products in the Environment: Current State of Knowledge and Monitoring Requirements
• Human Health Pharmaceuticals in the Environment - An Introduction
• Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment
• Human health risk assessment of carbamazepine in surface waters of North America and Europe
• Human Health Risk Assessment of Penicillin/Aminopenicillin Resistance in Enterococci Due to Penicillin Use in Food Animals
• Human health risk assessment of pharmaceuticals in water: An uncertainty analysis for meprobamate, carbamazepine, and phenytoin
• Human pharmaceuticals in surface waters: Implementation of a prioritization methodology and application to the French situation
• Human pharmaceuticals in the aquatic environment - A review
• Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry
• Human pharmaceuticals in the environment: current and future perspectives
• Human pharmaceuticals in US surface waters: A human health risk assessment
• Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1
• Human pharmaceuticals, antioxidants, and plasticizers in wastewater treatment plant and water reclamation plant effluents
• Human pharmaceuticals, hormones and fragrances: The challenge of micropollutants in urban water management
• Human Pharmaceuticals, Hormones, and Personal Care Product Ingredients in Runoff from Agricultural Fields Irrigated with Treated Wastewater
• Human Pharmaceuticals: Assessing the Impacts on Aquatic Ecosystems
• Human risk assessment of organic contaminants in reclaimed wastewater used for irrigation
• Human use pharmaceuticals in the estuarine environment: A survey of the Chesapeake Bay, Biscayne Bay, and Gulf of the Farallones
• Hydrolysis and photolysis of oxytetracycline in aqueous solution
• Hydrophilic and amphiphilic water pollutants: using advanced analytical methods for classic and emerging contaminants
• Hydrophilic Anthropogenic Markers for Quantification of Wastewater Contamination in Ground- and Surface Waters
• Hydroxy Benzoate Preservatives (Parabens) in the Environment: Data for Environmental Toxicity Assessment
• Hydroxyl Group Derivatization of Steroid Environmental Endocrine Disrupting Chemicals
• Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies
• Hypochlorite oxidation of select androgenic steroids
• Hypoxia Does Not Influence the Response of Fish to a Mixture of Estrogenic Chemicals
• Identification and enantioselective gaschromatographic mass-spectrometric separation of O-desmethylnaproxen, the main metabolite of the drug naproxen, as a new environmental contaminant
• Identification and significance of phenazone drugs and their metabolites in ground- and drinking water
• Identification of a phytotoxic photo-transformation product of diclofenac using effect-directed analysis
• Identification of Antibiotic-Resistance-Gene Molecular Signatures Suitable as Tracers of Pristine River, Urban, and Agricultural Sources
• Identification of centrarchid hepcidins and evidence that 17β-estradiol disrupts constitutive expression of hepcidin-1 and inducible expression of hepcidin-2 in largemouth bass (Micropterus salmoides)
• Identification of estrogenic compounds in wastewater effluent
• Identification of estrogen-like effects and biologically active compounds in river water using bioassays and chemical analysis
• Identification of intermediates and assessment of ecotoxicity in the oxidation products generated during the ozonation of clofibric acid
• Identification of methyl triclosan and halogenated analogues in male common carp (Cyprinus carpio) from Las Vegas Bay and semipermeable membrane devices from Las Vegas Wash, Nevada
• Identification of Retinoic Acid Receptor Agonists in Sewage Treatment Plants
• Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment
• Identification of Transformation Products of Organic Contaminants in Natural Waters by Computer-Aided Prediction and High-Resolution Mass Spectrometry
• Identification of Xenoestrogens in Food Additives by an Integrated in Silico and in Vitro Approach
• Identifying Future Drinking Water Contaminants
• Identifying model pollutants to investigate biodegradation of hazardous XOCs in WWTPs
• Identifying New Persistent and Bioaccumulative Organics Among Chemicals in Commerce
• Illicit drugs and pharmaceuticals in the environment – Forensic applications of environmental data, Part 1: Estimation of the usage of drugs in local communities
• Illicit drugs and pharmaceuticals in the environment – Forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination
• Illicit drugs in Canadian municipal wastewater and estimates of community drug use
• Illicit drugs in the environment
• Illicit drugs in the environment: Emerging contaminants and indicators of drug abuse
• Illicit Drugs in the Urban Water Cycle
• Illicit drugs, a novel group of environmental contaminants
• Illinois Governor Orders State Waters Tested for Drugs
• Immune-Mediated Adverse Drug Reactions
• Immunochemical determination of oxytetracycline in fish: Comparison between Enzymatic and Time-Resolved Fluorometric assays
• Immunochemical Determination of Pharmaceuticals and Personal Care Products as Emerging Pollutants
• Immunological Determination of the Pharmaceutical Diclofenac in Environmental and Biological Samples
• Immunotoxicological effects of an activated-sludge-treated effluent on rainbow trout (Oncorhynchus mykiss)
• Impact of biosolids on the persistence and dissipation pathways of triclosan and triclocarban in an agricultural soil
• Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal
• Impact of Environmental Chemicals on Key Transcription Regulators and Correlation to Toxicity End Points within EPA's ToxCast Program